P1A0
• Single post
lifeLSCS on indication antepartum eclampsia was suspected.( D-15)
fetus intrauterine
•• Multiple congenital anomaly
Single life fetus intrauterine
•• Umbilical cord cyst
Hydrocephalus was suspected
ec bilateral ventriculomegaly
•• AEDV Meningocele
•• Dolichocephalic
Single life fetus transverse lie
•• Meningoencephalocele
Covid-19 confirmed
•
• G5P3A1 Single life
32fetus
weekscephalic presentation
gestational age not in labor
•• Meningocele
Single life fetus cephalic presentation
• Dolichocephalic
••G1P0A0 Placenta4accrete
weeks gestational age Intrauterine
spectrum disorder was suspected
•• Single life
Prior CS 2x fetus cephalic presentation
• G2P1A0• Single life
16fetus
weekscephalic presentation
gestational age
•• Single life fetus
HSV I Infection intrauterine
•• Single life fetus
Hiperthiroid on intrauterine
therapy
•• Single
Single life
life fetus
fetus transverse
cephalic presentation
lie
•• Meningoencephalocele
Systemic lupus erythematous
•• Single lifelupus
Systemic fetus erythematous
cephalic presentation
•• Single life fetus intrauterine
ß-thalassemia
•• Single
Single life
life fetus
fetus intrauterine
cephalic presentation
• IUGR was suspected
• P3A0 post spontaneous delivery ( 44 hours outside)
• History of Early post partum hemorrhagic caused by perineal laceration
horner syndrome + intrauterine infection+ IUGR +
Fetal Post
P1A1 hypoperfusion
LSCS o.i fetal distress and
P1A0 post LSCS on12indication
history of PROM hours
cephalo-pelvic disproportion Day 8th
P1A0 Post LSCS on indication impending eclampsia day 7th
P1A0
• P2A0Post spontaneous
post deliveryprior
LSCS on indication withCS
history of PROMprevia
1x + placenta 18 hours day 4th
marginal (day 13th )
• Post IUD insertion
P3A0 with controlled Diabetes Mellitus Type II
• Post tubal ligation
• P3A0 Post SSTP on indication fetal distress
P1A0 post LSCS on indication cephalopelvic disproportion caused by hydrocephalus day 9
P2A0 post caesarean hysterectomy o.i uterine atony + Impending eclampsia + Prior CS 1x
• Nephrotic syndrome caused by GNAPS was suspected dd/ lupus nephritis ( M32.9)
•(I10)
Single life fetus intrauterine
• Sigle life fetus
Moderate anemia intrauterine
caused by(Z37.0)
iron deficiency
• SLF cephalic presentation (Z37.0)
Single life fetus cephalic presentation presentation ( Z37.0)
• Fetal tend to be (small
Hydrocephalus Q89.9) ( P06.9)
• Anhydramnios
HIV infection ( (B20) O41.1)
••G3P2A0
Single life 16fetus
weeks cephalic presentation
gestational age ( Z37.0)
• Single life fetus intrauterine
••G1P0A0
Single life 7 weeks gestational (age
fetus intrauterine Intrauterine
Z37.0)
Anhydramnios
• SLF intrauterine
• Endometriosis
Ventricel septalcyst defect
• Intrauterine
Moderate anemia restriction
growth
• SLF cephalic presentation
Bad obstetric history
• Twin death fetus
Single life fetus cephalic presentation ( Z37.0)
Meningoencephalocele
• Dermoid ( Q89.9) unilateral salpingo-oophorectomy) (D27.9)
cyst ( post laparotomy
••G5P3A1
Single life 35fetus
weeks intrauterine
gestational(Z37.0)
age not in labor (Z3A.35)
Single lifelupus
• Systemic fetuserythematous
cephalic presentation ( Z37.0)
with arthritis manifestation ( M32.9)
Single life fetuspreeclampsia
• Superimposed intrauterine (onZ37.0)
chronic hypertension (O14.03)
•(N18.9)
Single life fetus intrauterine ( Z37.0)
Single life fetus(O41.0)
Anhydramnios intrauterine (Z37.0)
IUGR was suspected (P059)
(O43.21)
Single life fetuscaused
Anhydramnios cephalic bypresentation (Z37.0)
renal agenesis + lung hypoplasia + cardiomegaly
(Q89.9)
Single life fetus cephalic presentation
(Z37.0)
G1P1A0
Placenta 18 weeks
accreta wasgestational
suspectedage with syphilis infection SLF intrauterine
Single life
Thyroid nodule fetus cephalic presentation
Single life
G2P1A0 20fetus
weeks intrauterine
gestational ag
Single life fetus intrauterine
cephalic presentation ( Z37.0)
Umbilical cord
Hepatitis B infection entanglement 2x
Single life
Myoma fetus
uteri cephalic
cystic presentation
degeneration
Single
HIV life fetus(B.20)
infection cephalic presentation
Singlelife
Twin lifefetus
fetusintra
cephalic presentation
uterine
TTTSlaparatomy
post was suspected salphyngooophorectomy sinistra on indication dermoid cyst
Single life fetus intrauterine
cephalic presentation
Asymmetric IUGR
Single life fetus intrauterine
Subchorionic
Single life fetus bleeding
cephalic presentation (Z37.0)
Meningo-encephalocele
prior CS 1x (Q89.9)
Single lifelupus
Systemic fetuserythematous
cephalic presentation
(M32.9)
Single dead fetus intrauterine
•G3P2A0 19 weeks gestational age (Z3A.16)
•Prior histerotomy
•G4P2A1 1x (O34.21)age (Z3A.28)
26 weeks gestational
•Prior CS72x
•G3P2A0 (O34.22)
weeks gestational age (Z3A.7)
•Prior CS33
·G3P2A0 2xweeks
(O34.22)
gestational age not in labor ( Z3A.30)
·Prior CS 2x ( O34.21)
·G1P0A0 37 weeks gestational age not in labor (Z3A.35)
·Single life
•G1P0A0 fetus cephalic
9 weeks presentation
gestational age (Z3A.9)presentation ( Z37.0)
•SLE mild
•G4P2A1 activity
36-37 weekswith arthritis and
gestational agemucocutaneous
( Z3A.30) manifestation (M32.9)
•Prior CS81x
·G2P1A0 (on indication
weeks gestationalpost
ageterm) (O34.21)
(Z3A.8)
·Systemic28lupus
·G1P0A0 weeks erythematosus
gestational age (M32.9)
(Z3A.28)
·Superimposed
·G4P3A0 preeclampsia
37 weeks not in labor(O11.9)
(Z3A.37)
·Single life
·G2P1A0 22 fetus
weekscephalic presentation
gestational age (Z3A.18)
·Latent syphilis infection (M32.9)
·G3P0A2 8 weeks gestational age (Z3A.8)
·Bad obstetric
·G1P0A0 history
12 weeks (O09.299)
gestational age (Z3A.12)
·Dermoid cyst was suspected (D279)
·G1P0A0 12 weeks gestational age (Z3A.8)
·Systemic29lupus
·G1P0A0 weeks erythematosus
gestational age (M32.9)
(Z3A.8)
·Single life
·G1P0A0 31 fetus
weekscephalic presentation
gestational age (Z3A.31)
·Single life
G3P2A0 fetus cephalic
20 weeks presentation
gestational (Z37.0)
age (Z3A.20)
HSV I infection
G4P3A0 24 weeks(B00.9)
gestational age (Z3A.24)
SLE arthrititis manifestation
G2P1A0 14 weeks gestational (M32.9)
age (Z3A.14)
Prior CS37
G3P2A0 1x weeks
(034.21)gestational age (Z3A.37)
Prior CS30
G1P0A0 2x weeks
(034.21)gestational age (Z3A.30)
Single life fetus breech
G3P2A0 18 weeks gestational presentation (Z37.0)
age (Z3A.18)
Single life
G2P1A0 37fetus
weeksintrauterine (Z37.0)
gestational age not in labor (Z3A.37)
Prior CS38
G3P2A0 1x weeks
(O34.21)gestational age not in labor (Z3A.38)
Uterine
P5A0 myom
post LSCS (D25.9)
on indication anhydramnion (day 9th) (34.21)
P2A3 post LSCS on indicationon
Superimposed preeclampsia chronic
prior CS 1xhypertension
+ transverse(O14.13)
lie (day 9th) (O34.21)
P2A0 post spontaneous delivery (outside) (day 9th) (650)
Post curettage
Cervical Canceron indication
Stage early
IIIB was hemorrhagic
suspected post partum caused by rest of placentae (O73.1) LPP
( C53.9)
Cervical Cancer Stage IIIB ( C53.9) on radiotherapy
Moderate
Cervical anemia
Cancer ( D64.9)
Stage IIIB ( C53.9)
Moderate anemia ( D64.9)
Cervical Cancer Stage IIIB ( C53.9)
Ovarian Cancer Stage IIIC ( C56.9) complete therapy complete response
Ovarian Cancer Stage IIIC ( C56.9) complete therapy complete response
Ovarian Cancer Inadequate staging ( C56.9)
GTN Stage I FIGO Score 3 ( O01.9)
Right solid ovarian neoplasm ( C56)
Left cystic
Cystic ovarian
ovarian neoplasm
neoplasm ( N83.02) was suspected ( C56.9)
with malignancy
Ovarian cancer Inadequate staging ( C56)
Ovarian cancer Stage IA ( C56)
Leucopenia
Ovarian cancer( C72.819)
Stage IVA ( C56)
Hydatidiform mole was suspected ( O01.9)
•G4P2A1 39 weeks gestational age (Z3A.39)
•Prior CS35
•G1P0A0 1Xweeks
(O34.21)
gestational age (Z3A.35)
•Beta thalassemia intermediate (D56.1)
•P6A1 post SSTP oi Superimposed preeclampsia + PPHD NYHA IV (days 10th)
•Post post
•P1A0 tuba spontaneous
ligation (daysdelivery
10th) (O34.21)
with history of rupture of membrane (day 20th) (O34.21
•P3A0 post LSCS oi placentae previa with prior cs 1x (days 8th ) (O34.21)
•Post pomeroy tubectomy (days 8th)
Diagnosa
G3P2A0 29 weeks gestational age (Z3A.29)
Prior histerotomy 1x (O34.21)
CKD stage V on HD (N18.9)
Single life fetus transverse lie (032.2)
Diagnosa
G2P1A0 35 weeks gestational age (Z3A.31)
SLE mild activity with arthritis manifestation (M32.9)
Single life fetus cephalic presentation (Z37.0)
Intrauterine growth restriction (Z36.4 )
G4P2A1 31 weeks gestational age (Z3A.31)
Single life fetus cephalic presentation (Z37.0)
Teratoma sacrococcygeal (Q76.428)
diagnosa
Single life fetus intrauterine
SLF cephalic presentation
Multiple congenital syndrome
Polyhydramnios
SLF intrauterine
Anhydramnios
P1A0 post LSCS on indication hydrocephalus (Z37.A) Day 13
Post IUD insertion postpartum
Single life fetus intrauterine
SLF cephalic presentation
Multiple congenital syndrome
Polyhydramnios
SLF intrauterine
Anhydramnios
IUGR
SLF intrauterine
G5P3A1 27 weeks gestational age single life fetus intrauterine (Z3A.27)
SLF cephalic presentation
Polyhydramnios (O40)
SLF intrauterine
SLF fetus intrautereine
SLF cephalic presentation
Hydrocephalic caused by holoprocenphaly semi lobaris (O35)
Wound dehiscene on perineal suture (recovery)
P4A1 post LSCS o.i conjoint twins omphalo-thoracophagus + post tubectomy pomeroy (days 10th)
P4A0 post spontaneous delivery preterm with superimposed preeclampsia IUFD(days 10th)
IUGR
SLF intrauterine
G5P3A1 27 weeks gestational age single life fetus intrauterine
SLF cephalic presentation
Wound dehiscene on perineal suture (recovery)
P2A0minilaparatomy
Post post LSCS oi Anhidramnios
tubectomy with history PROM 1 day (days 10)
Fistula recto-vaginal
Sub involusi uteri
DNA Folickaryotype
acid 1x1 examination
FeSO4 1x1 avidity test
Toxoplasma
•BPP evaluation
CaCo3 1x1
•• Folic CaCo3 1x11x1
acid
•Laboratory
Folic acid examination
1x1
LSCS
CaCO3 1x1
Folic acid
Folic acid 1x1
1x1
Plan
Folic acid 1x1 CS (22/2/21)
for elective
•FeSO4 1x1
Tocolytic
•• Multidiscipline
CaCO3 1x1 team
•• FolicCaCO3 acid
1x11x1
•• Folic
CaCO3 acid
1x11x1
•• Control
Internal (16/3/21)
medicine assesment
•• CaCo3
Pro cystoscopy
1x1
•• Folic
Folic acid
acid 1x1
1x1
•• CaCo3 2x1
FeSO4 1x1
Vitamin
CaCO3 3x1 D 1x4
•FeSO4 1x1
Hospitalized
Plan for LSCS
• Contraception counselling
• IUD Insertion
Counseling for contraception choice à
patient toilet
Wound agreed for IUD interval
CIE
Wound care
CIE
• Wound care à removal wound dressing.
•Family
CIE planning counselling
•CIEHigh protein
Diet
• Family planning counselling
•• IUD
HighInsertion
protein
•Diet
High protein
•Diet
High protein
Diet
• High protein
Diet
Furosemide 1x40 mg
Multivitamin
Metyldopa 3x250mg
• Multivitamin
ARV drug ( 99.21)
• Plan
Folicfor
acidLSCS
1x1 (74.1)
• CaCO3
Laboratory1x1examination (TORCH) ( V72.62)
••Control
Plan for( LSCS
March,( 74.1)
22nd 2021)
Continued
• FeSO4 1x1ARV therapy ( 99.21)
Laboratory
• Folic examination
acid 1x1
••Control
FeSO4 1x1
•( March,
Folic acid16th
1x12021)
• FeSO4 1x1
• Control April 6th 2021
••Hospitalized
Laboratory examination
• Plan for LSCS (March 12th 2021)
• Plan for DnC
Elective CS ( March, 15th 2021) ( 74.1)
Laboratory
• Folic examination and anesthesia consult ( March, 11th 2021) (V72.62; 89.09)
acid 1x1
• FeSO4 1x1
Control ( March,
• Folic acid 1x1 17th 2021)
FeSO4 1x110mg 1x1
• Nifedipine
•Low
Aspirin 80mg 1x1
salt diet
HD
Lungasmaturation
scheduled (dexamethason 12mg twice every 24 hr) (659.8)
Ultrasound
Fe tablet 1x1 confirmation (88.7)
Folic acid
CaCO3 tab 1x400mcg
3x500mg
Fe tabfor3x1
Plan C-Section with TAH
Stable in VK
Control
Laboratory
Fe tablet 1x1 exam
Folic acid tab 1x400mcg
Control on 18.03.2021
Laboratory
Vit D 1000 examination
2x1
Folic acid tab
Fe tablet 1x300mg1x400mcg
Plan for LSCS
Fe tablet 1x300mgon March 29th 2021
Plan for LSCS on March 31st 2021
Control on April 1st 2021
Control on April 1st 2021
Referred to Harapan Kita Hoespital for fetal therapy
Control on April 15th 2021
Control
Consulton to April 1st 2021
oncology surgery
Control on April 15th
Control ( March, 25th 2021) 2021
Plan for LSCS
Control on April 1st 2021
Plan for curretage à patient refused
•Control
on March, 26th 2021
•Control
on April, 16th 2021
•Control
on April, 16th 2021
•Hospitalized
•Plan for LSCS
•Control
on March, 29th 2021
•Control
on April,
•Plan for 20th 2021
Elective caesarean section in 38 weeks gestational age
•Control
In 4 weeks
•Control
on March, 31st 2021
•Control
on March, 31st 2021
•Control
in a 4 weeks
•Control
in a 4 weeks
•Control
In 3 weeks
•Control
in a 4 weeks
•Control
in a 2 weeks
•Control
in a 2 weeks
Control on the next 4 weeks
Evaluation ofHospitalized
Suggestion: HSV I IgG IgM leveltranfusion
for PRC
Folic acid
Control on 3x1
the next 4 weeks
Education : Plan for PRC tranfusion
Hospitalized
Plan foron
Control elective
the nextLSCS after general condition improvement
4 weeks
Education
Control on the next 4 weeks
USGfor
Plan evaluation in 1 month
elective LSCS on April 22nd 2021 (74.1)
Consult
Plan to anesthesia
for elective LSCS department
on April 15th 2021 (74.1)
Consult to anesthesia
Wound Care (96.5) department
Antihypertension
Family (E94.2) (V65.40)
planning counselling
Woundplanning
Family Care (96.5)
counselling (V65.40)
Plan for Clinical staging
Hospitalized
PRC transfusion ( 99.04)
Hospitalized
PRC transfusion
Chemotherapy ( 99.04)
paclitaxel-carboplatin 1st course ( 99.25)
Plan for radiotherapy ( June,
Tumor marker evaluation ( V72.4) 29th 2021) ( 92.29)
Tumor marker evaluation ( V72.4)
Laparoscopy conservative surgical staging ( 54.21)
MR Chemotherapy 14th course ( 99.25)
Laparotomy VC ( 54.1)
Laparotomy VC ( 54.1)
Laparotomy surgical staging ( 54.1)
Hsoptialized
Leucogen
BEP injection 2nd
Chemotherapy ( 99.21)
course ( 99.25)
Hospitalized
Laboratory examination ( V72.62)
•Hospitalized
•Controlfor
•Plan inelective
1 week cesarean section (20.04.2021)
•Education
•CIE(E94.2)
•CIE
•Plan for consult Internal Medicine department
•CIE(E94.2)
•Antibiotic
•CIE
Procedure
Control in 1 week
Medication (99.21)
- CaCO3 3x500mg
- Folid acid 1x400mg
- Sulfas ferrous 1x1
Nifedipine 1x10mg
Heparin 5000/12 hours (SC Injection)
Education :
- Water intake
restriction
- Low salt diet
- HD as scheduled
Control in 1 weeks
FeSO4 tab 1x300mg
Folic acid 1x400mcg
CaCO3 tab 3x500mg
Procedure
Hospitalized
Laboratory examination
Lung maturation
US confirmation
Control in 2 weeks
Education
Folic acid 1x400mcg
CaCO3 tab 3x500mg
Sulfas ferrous 1 x 1 tab
Control in 1 week
Cardiologist and Anasthesia consultant
Control in 1 weeks
Planning for C-Section and Laparotomy FS on June 14th 2021
Calc 1x1
Calc 1x1
roborantia
Elective CS and tuba ligation on Monday September 6th. 2021
ASI on demand
ASI on demand
Antihypertension
LSCS
PRC transfusion until Hb > 10 g/dL
Folid acid 1 x 1
Plan for elective sectio secarea and tubectomy
ASI on demand
Mini laparotomy
Repair Tubectomy
fistula ( 3 months post partum)
USG confirmation
ree (M32.10)
ation (M32.10)
nephritic (M32.9)
ation) (M32.10)
ation (M32.10)
nephritic (M32.9)
ation) (M32.10)
Mrs.SISKA
70 Maret 12.03.2021 WIDARSIH / 35 YO/ 1200191/PALEMBANG/STI-HAD/HE
Mrs.
71 Maret 16.03.2021 YOSI YUNITA/ 25 YO/ 1200410/BENGKULU/ STI-HAD/ HE
Mrs.
Maret 16.03.2021 MAYANG TARI/ 29 YO/ 1200455/PALEMBANG/STI-HAD/AB
71
Mrs.
Maret 17.03.2021 KHO/ 25 YO/ 1200625/ BANYUASIN/ STI-HAD/ NS
Mrs.
Maret 17.03.2021 KHO/ 25 YO/ 1200625/ BANYUASIN/ STI-HAD/ NS
72
Mrs.
Maret 17.03.2021 NOV/ 31 YO/ 1200589/PALEMBANG/ STI-HAD/ NS-HD
72
73
1 Agustus 5
2 Agustus 5 CAR, 45 tahun, Palembang
1 Desember
03/12/2021 Mrs. MAR/ 37 th/ 785223/ PALEMBANG/ CAY-ZAN
2 Desember
09/12/2021 Mrs.RANI ANGGRAINI / 31YO / 1236288 / PALE
3 Desember
09/12/2021 Mrs.NI LUH PUTU SUKERTI / 38YO / 1236293 /
4 Desember
09/12/2021 Mrs. FITRI HANDAYANI/ 21 YO/ 1236324/BANY
5 Desember
03/12/2021 Mrs. DES/ 21 YO/ 1237129/ Banyuasin/ BER-THR/
6 Desember
10/12/2021 Mrs. HEN/ 26 YO/ 1236426/ Palembang/ BER-MIQ/
7 Desember
8 Desember 10/12/2021 Mrs. NYI/ 27 YO/ 1236379/ Palembang/ BER-MIQ/
9 Desember
03/12/2021 Mrs. SIK/ 37YO 1229812
PALEMBANG
CAY-ZAN-UFA/ HI
10 Desember
03/12/2021 Mrs. SIH/ 29YO 1229802
63 Desember
63 Desember
03/12/2021 Mrs. NOV / 32 YO
808444
PALEMBANG
CAY-ZAN-SAR / HI
70 Desember
03/12/2021 Mrs. IRM/ 33 YO/ 1233875/ Palembang/ DPR-CIA-U
76 Desember
27.11.2021 Mrs. MAI/ 30 YO/ 1233948/ OGAN ILIR/ DPR-CIA
06.30 PM 27.11.2021
83 Desember
03/12/2021 Mrs. ANG/ 22 YO / 706277/ Palembang/ DPR-CIA-U
93 Desember
28.11.2021 Mrs. ROY/ 32 YO/ 1233993/ Ogan Ilir/ ASR-RAM-
98 Desember
28.11.2021 TUT/ 25 YO/ 915283/ Musi Banyuasin/ 915283/ JAY
104 Desember
29.11.2021 Mrs.MUN/ 45 YO/ 123407/ Banyuasin/ BAN-KOM-
110 Desember
29.11.2021 Mrs. IRA/ 31 YO/ 1234081/ Palembang/ BAN-KOM
115 Desember
30.11.2021 Mrs. FEB/42 YO/ 1234339/ PALEMBANG/ JAY-O
122 Desember
30.11.2021 Mrs. ISR/ 28 YO/ 1122713/ Ogan Komering Ilir/ C
127 Desember
03/12/2021 Mrs. SIM/ 45 YO/ 1234558/ Banyuasin/ BER-INO-SA
135 Desember
30.11.2021 Mrs. LOM/ 37 YO/ 1234460/ Palembang/ GIO-OSP/
02.10 PM
140 Desember
01.12.2021 Mrs. NUR/ 27 YO/ 1234780/ Banyuasin / IYA-CIA
09.00 PM
147 Desember
02.12.2021 Mrs. DIN/ 19 YO/ 935116/ Palembang/ IYA-CIA-SA
02.10 AM
151 Desember
151 Desember
03.12.2021 Mrs. YUS/ 34 YO/ 998580/ Palembang/ GAS-IZY-OS
158 Desember
03/12/2021 Mrs. TRI/ 24 YO/ 1235065/ Palembang/ CAY-MIQ/
166 Desember
03/12/2021 Mrs. MAY/ 33 YO/ 525542/ Palembang/ CAY-THR/
171 Desember
06/12/2021 Mrs. DIA/ 24 YO/ 1235463/ Palembang/ BER-MIQ/
175 Desember
06/12/2021 Mrs. ROS/ 42 YO/ 388712/ Batam/ P0A1/ BER-MIQ/
179 Desember
08/12/2021 Mrs. VER/ 34 YO/ 1236021/ Riau/ BER-THR/AB
188 Desember
09/12/2021 Mrs. MUS/ 27 YO/ 1075896/ Ogan Ilir/ BER-THR/ N
195 Desember
195 Desember
03.12.2021 Mrs. AMA/30 YO/749065/Palembang/KOM-KIS/AF
201 Desember
03.12.2021 Mrs. RIZ/29 YO/704796/Palembang/G4PA1
209 Desember
06.12.2021 Mrs. YES/34 YO/9999580/Palembang/G3P2AO/KIS
215 Desember
07/12/2021 Mrs. UMM/32 YO/1234641/Palembang/G4P2A1
223 Desember
07/12/2021 Mrs. FIT/35 YO/Palembang/G4PA0
229 Desember
OBSTETRIC INPATIENT
Diagnosa
G2P1A0 39 weeks gestational age not in labor
COVID-19 was suspected
Single life fetus transverse lie
• G2P0A1 38 weeks gestational age inlabor first stage laten phase ( Z3A.38)
• Single life fetus breech presentation (O32.1)
• Umbilical cord Entanglement twice
Recent diagnosis
• P1A1 post SLCS o.i breech presentation + umbilical cord Entanglement twice
• G1P0A0 31 weeks gestational age inlabor first stage latent phase ( Z3A.31)
• Antepartum hemorrhagic caused by placenta abruption (O45)
• Single dead fetus transverse lie ( O32.2)
Recent diagnosis
P1A0 post LSCS on indication placenta abruption + post ß-lynch modification
• G1P0A0 31 weeks gestational age inlabor first stage latent phase ( Z3A.31)
• Antepartum hemorrhagic caused by placenta abruption (O45)
• Single dead fetus transverse lie ( O32.2)
Recent diagnosis
P1A0 post LSCS on indication placenta abruption + post ß-lynch modification
• G1P0A0 39 weeks gestational age inlabor first stage laten phase ( Z3A.39)
• Covid -19 was suspected (U07.2)
• Single life fetus transverse lie (O32.2XX0)
Recent diagnosis
•G2P1A0
Single life38 weeks
fetus gestational
cephalic age not in labor (Z3A.38)
presentation
•HIV infection (O98.7)
G3P2A0 34 weeks gestational age not in labor (Z3A.37)
Prior CS
P2A1 post2x (O34.21)
LSCS on indication marginalis placenta previa with prior CS 1x with breech presentation (outside) (14th d
G3P1A1 35 weekswas
Placenta percrete suspected
gestational agewith placenta in situ (043.23)
(Z3A.37)33 weeks gestational age not inlabor (D26)
G3P2A0
Prior CS 32
G2P0A1 2x weeks gestational age not inlabor (Z3A.32)
ASD + Eisenmenger
G3P2A0 syndromeage
38 weeks gestational wasnotsuspected (Q21.1)
in labor (Z3A.38)
Prior CS
·P2A1 post
Asymptomatic 2xspontaneous
(O34.21) delivery
urinary tract (2 hours outside) (O80.0)
infection
·Early postpartum hemorrhage caused by vaginal laceration (O72.1)
·G5P1A3
P4A0 37 weeks34 weeks gestational
gestational age age not in
in labor labor
first ( Z3A.33)
stage latent phase
·PROM 1 day (O42.10)
P1A0 Post spontaneous delivery (O80), mild anemia (D64.9)
P1A0 Post LSCS on indication fetal distress, intrauterine infection, history of ROM 1 day, an hydramnios
P5A0 Post spontaneous delivery with severe preeclampsia
Severe Anemia
P1A0 Post LSCS on indication Twin life-death fetus, intrauterine infection, severe oligohydramnios O31.0
DISCHARGED
Passed Away
On ICU at 06.00
•Covid-19 AM Monday,
was suspected April 12th, 2021
( U07.2)
•Single
P1A1 lifeLSCS
post fetus o.i
cephalic presentation (Z37.0)
malposition
P2A0 post preterm spontaneous delivery with acute myeloid leukemia
Covid 19 Was suspected (U07.1)
Single
G2P1A0 life22fetus intrauterine
weeks (Z21.0
gestational age, SLF intrauterine
Post cerclage on indication cervical
•P1A2 post LSCS of indication Cephalopelvicincompetence
disporpotion
•History of PROM 6 hours
•G2P1A0 41 weeks gestational age not in labor (Z3A.41)
•Singlelife
Single lifefetus
fetusintrauterine
cephalic presentation
( Z26.0) (Z37.0)
Anhydramnios
Single life fetus(O41.1)
cephalic presentation (Z37.0)
•Complete placenta previa with PASD was suspected (O44.1)
•Single life
Multiple fetus breech
intramural presentation
uterine myoma (O32.2)
Anhydramnion (041.0)
Asymmetric
•G2P1A0 6 weeks IUGRgestational
(P05.9) age ( Z3A.6)
•Hyperemesis
•Late post partum gravidarum gradecaused
hemorrhagic II (O21.1)
by retained placenta ( O73.1)
•Covid-19 was suspected ( IgG reactive) ( U07.2)
Diagnosa
G3P2A0 29 weeks gestational age (Z3A.29)
Prior histerotomy 1x (O34.21)
CKD stage V on HD (N18.9)
Single life fetus transverse lie (032.2)
Diagnosa
G2P1A0 35 weeks gestational age (Z3A.31)
SLE mild activity with arthritis manifestation (M32.9)
Single life fetus cephalic presentation (Z37.0)
Intrauterine growth restriction (Z36.4 )
G4P2A1 31 weeks gestational age (Z3A.31)
Single life fetus cephalic presentation (Z37.0)
Teratoma sacrococcygeal (Q76.428)
Recent diagnosis
P1A0 post LSCS on indication breech presentation with anhydramnios
Recent diagnosis
P1A0 post LSCS o.i oligohydramnios + Intrauterine infection
Recent condition
P1A0 post LSCS of indication malposition + inertia uterine
Recent Diagnosis
P3A0 post LSCS o.i impending eclampsia
Recent diagnosis
P1A0 post LSCS on indication failed of induction
G3P1A1 37 weeks gestational age in labor first stage active phase ( Z3A.37)
Prior CS 1x on indication anhydramnios (O34.21)
Single life fetus cephalic presentation
Recent diagnosis
P2A1 post spontaneous delivery with prior CS 1 x
Diagnosa
G2P1A0 40 weeks gestational age (Z3A.40)
Prior CS 1x (O34.21)
Covid 19 was suspected (U07.2)
SLF cephalic presentation (Z37.0)
Recent diagnosis:
G2P1A0 40 weeks gestational age (Z3A.40)
Prior CS 1x (O34.21)
G2P1A0 34 weeks gestational age not in labor (Z3A.34)
Antepartum hemorrhagic caused by complete palcenta previa ( O44.03)
Severe preeclampsia ( O14.03)
Moderate anemia (hypochromic microcytic) (D64.9)
SLF cephalic presentation ( Z37.0)
IUGR was suspected
Recent diagnosis :
P2A0 Post LSCS on indication Antepartum hemorrhagic caused by complete palcenta prev
Severe preeclampsia
Recent diagnosis:
P1A1 post LSCS on indication Eclampsia antepartum
Complete HELLP syndrome
Recent diagnosis :
P3A0 post spontaneous delivery
Prior CS 2X
COVID-19
Covid confirmed(U07.1)
19 confirmed
Post Tubectomy
Covid-19 pomeroy
infection (66.1)
was suspected
Covid 19 Confirmed
Post curettage on indication rest of placenta
Post brand Andrew manuver on indication incarcerated of placentae
Multiple uterine myoma
Recent diagnosis
P2A0 post LSCS on indication prior CS 1x + interdelivery <18 months
Covid-19 confirmed (U07.1)
Post curettage on indication rest of placenta (O73.0)
Probable Covid 19 confirmed (U07.1)
Covid-19 was confirmed
Covid 19 was suspected
Covid 19 was suspected
Diagnosa
•G2P1A0 34 weeks gestational age not in a labor (Z3A.3)
•Cervival funneling (Y type)
•Cervical shortening 0,42 cm (O34.3)
•TLF transverse lie -breech presentation (Z37.0)
•G2P1A0 37 weeks gestational age not in a labor (Z3A.3)
•Systemic Lupus Erythematous Mild Degree (Mucocutaneous Manifestation) (M32.10)
•SLF cephalic presentation (Z37.0)
•G1P0A0 37 weeks gestational age not in a labor (Z3A.3)
•Intramural uterine myoma (D26.7)
•SLF cephalic presentation (Z37.0)
•G2P1A0 28 weeks gestational age not in a labor (Z3A.2)
•Prior CS 1x (on indication HIV) (O34.21)
•HIV infection (B 20.3)
•SLF cephalic presentation (Z37.0)
•G4P3A0 24 weeks gestational age (Z3A.2)
•Chronic Myelogenous Leukemia (CML) (C92)
•SLF intrauterine complicated by nuchal cord (O69.2)
•G3P0A2 25 weeks gestational age not in labor (Z3A.2)
•Secondary Antiphospholipid Syndrome (APS) ec SLE (O99.1)
•Hipothyroidism (O99.2)
•SLF intrauterine (Z37.0)
•G3P2A0 38 weeks gestational age not in labor (Z3A.3)
•Gallbladder stone (K08)
•SLF cephalic presentation (Z37.0)
•G2P1A0 37 weeks, not in labor (Z3A.3)
•SLF cephalic presentation (Z37.0)
•Fetal growth restriction (O36. 59)
•Umbilical cord cirfumference 1x (O43.123)
•G3P1A1 23 weeks gestational age
•Prior CS 1x oi anhydramnion (O34.1)
•TLF cephalic presentation (O30.029)
•Conjoined twin with dicephalic paraphagus (O30.029)
•G5P3A1 23 weeks gestational age (Z3A.2)
•Right dermoid cyst was suspected, dd/ Cystic ovarium neoplasm with solid part (N83.1)
•SLF intrauterine (Z37.0)
•G3P1A1 34 weeks gestational age not in labor (Z3A.3)
•Prior CS 1x oi malposition (O34.1)
•Post cerclage on indication cervical shortening + funelling (O26. 872.)
•SLF cephalic presentation (Z37.0)
•G3P1A1 23 weeks gestational age (Z3A.2)
•Prior CS 1x oi HIV infection (O34.1)
•HIV infection (O98.7)
•SLF intrauterine (Z37.0)
•G3P2A0 24 weeks gestational age (Z3A.2)
•Shypillis infection (O98.1)
•SLF intrauterine (Z37.0)
•G1P0A0 29 weeks gestational age not in labor (Z3A.29)
•Preterm premature rupture of membrane 3 days (O42.02)
•Asymptomatic urinary tract infection (O86.20)
•Moderate anemia caused by iron deficiency (D50.0)
•Single life fetus cephalic presentation (O32.2)
Oligohydramnios (O41.1)
•G7P5A1 38 weeks gestational age in labor first stage latent phase (O37)
•Prior CS 1x (oi anhydramnios) (O34.21)
•Single life fetus cephalic presentation (O32.2)
Recent diagnosis
P6A1 post spontaneous delivery with prior CS 1x
Post mini-laparotomy tubectomy (Pomeroy tubectomy)
•G5P2A2 30 weeks gestational age not in labor (Z3A.30)
•Single life fetus breech presentation (O32.1)
•Anhydramnios (O41.0)
•Lower urinary tract obstruction was suspected
•Umbilical cord loop 2x (O69.82X0)
Recent Diagnosis
•P3A2 Pos LSCS oi anhydramnios with congenital anomaly
•G1P0A0 39 weeks gestational age in labor first stage latent phase (Z3A.39)
•Moderate Anemia caused by iron deficiency (D64.9)
•Single life fetus cephalic presentation (Z37.0)
Recent diagnosis
qP1A0 Post spontaneous delivery
qIron deficiency anemia
•G2P1A0 35 weeks gestational age not in labor (O35)
•Prior CS 1x (oi total placenta previa) (O34.21)
•Total placenta previa (O44.10)
•Tumor previa caused by cervical myoma
•Uterine myoma (D26.0)
•Single death fetus cephalic presentation (O36.4)
•IUGR (03.59)
Recent diagnosis
•P2A0 Post LSCS on indication total placenta previa
•Post myomectomy o.i multiple intramural uterine myoma , subserous uterine myoma
•Post adenomyosis resection on indication uterine adenomyosis
•Post B-lynch suture on indication uterine hypotonia
•G2P1A0 35 weeks gestational age not in labor (O35)
•Prior CS 1x (oi total placenta previa) (O34.21)
•Total placenta previa (O44.10)
•Tumor previa caused by cervical myoma
•Uterine myoma (D26.0)
•Single death fetus cephalic presentation (O36.4)
•IUGR (03.59)
Recent diagnosis
•P2A0 Post LSCS on indication total placenta previa
•Post myomectomy o.i multiple intramural uterine myoma , subserous uterine myoma
•Post adenomyosis resection on indication uterine adenomyosis
•Post B-lynch suture on indication uterine hypotonia
•G1P0A0 34 weeks gestational age in labor first stage active phase (O34)
•Single life fetus cephalic presentation (O32.2)
Recent diagnosis
P1A0 post spontaneous preterm delivery
•P1A0 post spontaneous delivery 6 hours (outside) with post partum haemorrhage caused by
•Moderate anemia (D64)
•G3P2A0 39 weeks gestational age first stage in labor latent phase (Z3A.39)
•Prior CS 2x inter-delivery interval 11 months (O34.21)
•Moderate anemia (O99.01)
•Twin life fetus breech-breech presentation
Recent Diagnosis
P2A0 post LSCS on indication prior CS 2x inter-delivery interval 11 months and twin pre
Moderate anemia
•G2P1A0 39 weeks gestational age inlabor first stage latent phase (Z3A.39)
•Premature rupture of membrane 16 hours (O44.021)
•SLF cephalic presentation
Recent diagnosis
P2A0 post SSTP oi non reassure fetal status (low variability fetal heart rate) (O76)
· G1P0A0 35 weeks gestational age not in labor with blunt abdominal trauma
SLF cephalic presentation
G1P0A0 31 weeks gestational age in labor second stage with PPROM 1 day
SLF cephalic presentation
•Pelvic pain caused by cystic ovarian neoplasm was suspected dd/ Endometriosis cyst was
G6P4A1 39 weeks gestational age in labor first stage latent phase (Z3A .39)
Moderate Anemia (D64.9)
SLF cephalic presentation (Z37.0)
•G3P1A1 37 weeks gestational age inlabor first stage latent phase (Z3A.37)
•Antepartum hemorrhage caused by complete placenta previa (O44.10)
•Severe anemia microcytic hypochrome (D64.9)
•Single life fetus cephalic presentation (Z37.0)
•Fetal distress (O77.9)
•G2P1A0 38 weeks gestational age in labor first stage latent phase (Z3A.38)
•Prior CS 1x o.i failed of induction (034.21)
•LUS thickness 1.2 mm
•Single life fetus cephalic presentation (Z37.0)
•G1P0A0 39 weeks gestational age inlabor first stage latent phase (Z3A.39)
•Premature rupture of membrane 3 hours (O44.20)
•Mild anemia cb iron deficiency (D64.0)
•SLF cephalic presentation
•G2P0A1 38 weeks gestational age inlabor first stage active phase ( Z3A.38)
•Syphilis infection ( A53.9)
•SLF cephalic presentation
•Adhesiolysis
•Cesarean hysterectomy (68.3)
•Double J stent insertion
•Stab wound drain
Antibiotics
Anesthesia assessment
LSCS
Stabilization
Lateroposition
O2 3L/m
Urine catheter
Anticonvulsant
Antihypertension
Anesthesia assessment
LSCS
Laboratory examination
Chest-X-ray
EID assessment
Vaginal delivery
Stabilization
Lateroposition
O2 5L/m
Anticonvulsant
Antibiotic
Anesthesia assessment
LSCS
Stabilization
O2
Laboratory examination
Antihypertension
Anticonvulsant
ECG
Internal medicine assessment
Transfusion PRC
Medicinalis
Join care with renal divison
Stabilization
Lateroposition
O2
Plan for ICU treatment
Chest X ray
EID assessment
Antihypertension
Anticonvulsant
Internal medicine assessment
Hysterotomy
IUD Insertion
Laboratory examination
Anesthesiology assessment
Curettage
Stabilization 3 hours
Anticonvulsant
Antihypertension
Laboratory examination
Internal medicine assesment
Anesthesia assessment
LSCS
Conservative management
Laboratory examination
Lung maturation Dexamethasone 12 mg/24 hr IM (2 days)
Tocolytic: nifedipin 10 mg/6 hr PO
Plan for US confirmation
Laboratory examination
PIE assessment
Lung maturation
Plan for abdominal termination
Conservative management
Laboratory examination
Lung maturation Dexamethasone 12 mg/24 hr IM (2 days)
Tocolytic: nifedipin 10 mg/6 hr PO
PRC Transfussion
Plan for US confirmation
Laboratory examination
PRC Transfussion
Anesthesiology assessment
laceration suturing
Plan for curettage
LSCS
Stabilization
Laboratory examination
Internal medicine, EID and anesthesia assessment
Antihypertension
Anticovulsant
LSCS
Laboratory examination
Chest X-ray
Anestesia assessment
EID Assesment
LSCS
Perineal rupture repair
Laboratory examination
Conservative management
Tocolytic
US confirmation
Laboratory examination
Vaginal delivery
Laboratory examination
Inj. Dexametason 12mg (im)
Vaginal delivery
• Vaginal swab
Plan for US obstetric
• Hemoglobin electrophoresis
• PRC Transfussion
LSCS + tubectomy
Plan for pomeroy
LSCS 05.02.2021
Transfusion
Internal PRC until
medicine Hb >10gr/dl
and anesthesia assessment
LSCS
Internal medicine, neurology, P1 and anesthesia assessment
•LSCS
Brandt Andrew Manuver
• Perineal laceration suturing
Lung maturation
•· EID
Obstetric US examination
assessment
•· Vaginal delivery assessment
internal department
Ultrasound examination
• cystoscopy
LSCS
• Moderate anemia (microcytic hypochrome)
• Single live fetus cephalic
Cervical Ripening presentation
(misoprostol 25mcg/6 hours pv)
• Plan for vaginal deliveryà failed à plan for LSCS
LSCS
• Laboratory examination
• LSCS
PCR Swab
PRC transfusion
• Chest-X-Ray
••Laboratory
LSCS examination
LSCS
• Assesment vascular surgeon division
Plan for sectio secarea at February 19th 2021
• Antibiotic
• US confirmation
Anesthesia, EID assessment
•· PRC
LSCStransfussion
· Sectio
Plan forsecarea + hysterectomy
abdominal termination
· Antibiotic
Vaginal Delivery
· EID asessment
··Laboratory
LSCS examination
· Partial extraction
Transfusion PRC
Plan for LSCS
Tamponade
PRC transfusion
Internal medicine assessment
Vaginal delivery
Laboratory à failed à LSCS
examination
•LSCS
PRC transfusion
••Plan
Curettage
for vaginal delivery (Induction of labor ) à patient refused
• Plan for LSCS
Antibiotic
• US confirmation
Transfusion PRC
LSCS
LSCS
· Cesarean section
•· Hysterectomy
EID assessment
•· EID
Plan and
for LSCS
Anasthesia Assesment (89.09)
•· LSCS (74.1 ) tubectomy
EID assessment (89.09) (V25.2)
•· PTU
Vaginal
200delivery (650
mg/ 8 hours
·Internal
LSCS (74.1 )
medicine assessment ( 89.09)
High protein diet ( V67)
Plan vaginal delivery( 75.0)à failed
LSCS
· Lung maturation
··Observation
Antibiotics of vital sign , contraction and FHR
Plan for vaginal delivery
· Tocolitics
Lungassessment
· EID maturation(89.09)
· Plan for termination perabdominal (74.1)
procedure
· LSCS (74.1)
LSCS
LSCS
Tubectomy Pomeroy
Tubectomy Pomeroy
tubectomy Pomeroy
Multivitamin
• Multivitamin ( 99.21)
• Plan for LSCS (74.1)
• CaCO3 1x1
• Plan for LSCS ( 74.1)
• Continued ARV therapy ( 99.21)
• Laboratory examination
• FeSO4 1x1
( March, 16th 2021)
• Folic acid 1x1
• FeSO4 1x1 examination
Laboratory
• Plan for LSCS (March 12th 2021)
·Hospitalized
·Expectative
•Family management
planning counselling (V25.09)
•Wound
Tubal Care
Hysteroscopy (96.5)
LigationD&C (68.12)
(V26.51)
Plan for vaginal delivery (650)
IUD insertion (69.7)
US Confirmation
Tubal ligation
Caesarean section
LSCS (669.7)
Tubectomy Pomeroy (66.62)
IUD insertion (69.7)
·LSCS (74.1)
·Total abdominal
Laprotomy hysterectomy (68.4)
exploration:
•Total abdominal
·LSCS (74.1) hysterectomy (68.4)
·Total abdominal
·Cesarean hysterectomy (68.4)
section (74)
·Hysterectomy(68.4)
·LSCS (74.1)
LSCS (74.1) Pomeroy (66.62)
·Tubectomy
Total abdominal
·Laboratory
LSCS hysterectomy
(74.1)examination (68.4)
(V72.62)
·Antibiotic (99.21)
·Laboratory examination
Plan for vaginal delivery (V72.62)
·Antibiotic
Ferrous (99.21)
sulfat 300 mg/ 24 hours
Plan for curettage after general condition improvement (69.0)
EID assessment (89.0)
EID Assessment
LSCS (74.1)
•Laboratory examination
•MRI pelvic of vital sign, contraction and FHR
•Observation
•US confirmation
Laboratory ( in working
examination hours)
( V72.62)
EID assessment
Laboratory ( 89.09)( V72.62)
examination
Antibiotic (examination
Laboratory 99.21) ( V72.62)
Anaesthesiaexamination
Laboratory and EID assessment
( V72.62)( 89.09)
Plan for
P1A1 vaginal
post LSCS delivery
c.b ASD (Q21.1)
Severe
forpreeclampsia
Procedure
Plan (O42.10 )
vaginal delivery
Swab (74.2)
LSCS result à the result has not out yet
Plan for vaginal delivery ( 650.0)
Antibiotic ( 99.2)
Cerclage (67.51)
Tocolytic ( 99.21)
TOL – Failed - LSCS
Antibiotic ( 99.2)
LSCS ( 74.1)
OUTCOME
11.00 PM Life neonatus was born, female, weight 2500 gram, length 45 cm, A/S 8/9 FT AGA followed Placenta was
Lung maturation ( 99.21)
Antibiotic ( 99.2)
LSCS (74.1)
06.21 AM Life neonatus was born, female, weight 1600 gram, length 44 cm, HC 32 cm A/S 8/9 PT SGA
Recent condition
Stable in ward
Laboratory examination ( V72.62)
Cervical Ripening with misoprostol 25 mcg/6 hours (734)
Plan For Vaginal delivery (650) 🡪 Failure
LSCS (74.1)
Outcome
11.50 AM Life neonatus was born, male, weight 2750 gram, length 48 cm, HC 32 cm A/S 8/9 FT AGA
11.55 AM Placenta was delivered completely, weight 480 gram, umbilical cord length 46 cm, diameter 18x17 cm
Laboratory examination ( V72.62)
Vaginal delivery
Conservative management
Lung maturation
Tocolytic
Antibiotic
Recent condition
Stable in ward
Stabilization
Antihypertension and anticonvulsant ( 99.21)
Ophtalmology assesment
LSCS (74.1)
OUTCOME
02.00 PM Life neonatus was born, female, weight 3500 gram, length 48 cm, A/S 8/9 FT AGA followed Placenta was
Laboratory examination
Cervical ripening 🡪 misoprostol 25 mcg pervaginam 🡪 failed
LSCS
Outcome
04.20 PM Life neonates was born, male, weigh 3200 gram, length 48 cm, HC 32 cm, A/S 8/9
04.25 PM Placenta was delivered completely, weight 510 gram, umbilical cord length 43 cm, diameter 19x18 cm
Observation of vital sign, contraction and FHR
Conservative management
Antibiotics
Tocolitics
Lung maturation
PRC Transfusion
X-ray Thorax
EID assessment
Observation vital sign, contraction and FHR
Plan for TOLAC
Outcomes :
02.15 AM Life neonates was born, male, weight 2600 gram, length 46 cm, A/S 8/9
02.25 AM Placenta was delivered completely
Hospitalized
Lung Maturation
Dexamethasone 10 mg/ 24 hours for 2 days
Antibiotic
Ampicilin 1 gram / 6 hours Intravenous
Gentamycin 80 mg / 12 hours interavenous
Tocolytic:
Nifedipine 10 mg/ 6 hours (PO)
Plan for pregnancy termination
Control in 1 weeks
Planning for C-Section and Laparotomy FS on June 14th 2021
Outcome :
07.35 PM Male live neonatus was born, BW 2800 g, BL 47 cm, A/S 8/9 FT AGA
07.40 PM Complete placenta was born cpmpletely ,
Observation vital sign, FHR and contraction
Lung maturation 🡪 finished
Anticonvulsant : MgSO4 ~ protocol
Antihypertension
Urine catheter
PRC transfusion
LSCS
Outcomes
00.40 AM Life neonates was born, female, weight 1400 gram, length 37 cm, HC 29 cm APGAS
Score 8/9 FT AGA
00.45 AM Placenta was delivered completely,
Observation of vital sign, contraction, and FHR
Stabilization :
- Oxygen
- Antihypertension
- Anticonvulsant
Laboratory exam (V72.62)
LSCS
Outcomes : 06.08.2021 : 02.20 AM Life neonates was born, male, weight 1100 gram, length 37 cm, HC 29 cm APGA
00.45 AM Placenta was delivered completely,
Observation of vital sign, contraction, and FHR
Stabilization
Conservative management
Observation of vital sign, contraction, and FHR
PIE assessment
LSCS 🡪 no operative room 🡪 Vaginal delivery
Outcomes
03.45 AM Life neonates was born, female, weight 2650 gram, length 45 cm, A/S 8/9
03.50 AM Placenta
Conservative was delivered
management completely
🡪 maternal distress 🡪 LSCS
07.20 PM placenta delivered completely, weight 90 gram, umbilical cord length 29 cm, diameter 12x11 cm
Internal medicine Assesment
Vaginal delivery 🡪 rest of placenta 🡪 curettage
Brand Andrew manuver
Anasthesia assessment
LSCS (34.21)
Prosedur
•Observation of vital sign, contraction and FHR
•Laboratory examination
•Expectant management
•Maternal rehydration
•Lung maturation
•Antibiotic
•Iron supplementation
•Obstetric ultrasound examination
•Observation of clinical sign of infection and laboratory findings
•Observation of vital sign, contraction and FHR
•Laboratory examination (V72.62)
•Vaginal delivery (650)
•Mini-laparotomy tubectomy (66.1)
11.35 PM life neonate was born spontaneously, female weight 3250 g, length 51 cm HC 31 cm
•Observation of vital sign, contraction
•Laboratory examination
•Observation of vital sign, contraction
•Laboratory examination
•Cesarean section
•Myomectomy
•Adhesiolysis
•Adenomyosis resection
•B-Lynch
Outcome
10.05 AM death neonate was born, female, 1800 gram, body length 42 cm, maceration grade III
10.08 AM placenta was born completely, weight 400 gram, umbilival cord length 40 cm diameter 16x15 cm
•Observation of vital sign, contraction
•Laboratory examination
•Observation of vital sign, contraction
•Laboratory examination
•Cesarean section
•Myomectomy
•Adhesiolysis
•Adenomyosis resection
B-Lynch
procedure
• Observation of vital sign, contraction and FHR (V71.09)
• Laboratory examination (V72.62)
• Lung maturation (659.8)
• Tocolytic (644.03)
• Obstetric ultrasound (75.99)
•P1A0 post LSCS on indication fetal tachycardia + Asthma attack with moderate degree
•Stabilization (99.6)
•Laboratory examination (V72.62)
•Internal medicine and anesthesia assessment (89.09)
•Albumin 20 % every 24 hr
•LSCS (74.1)
•Stabilization
•Laboratory examination (V72.62)
•CTG
•LSCS (741)
P1 ward
Observation of vital sign, contraction and FHR
Laboratory examination
Plan for LCSC
•Stabilization
•Internal medicine and anesthesia assessment (89.09)
•Laboratory examination (V72.62)
•Antihypertension (99.21)
•Anticonvulsant (99.21)
•Plan for LSCS
•Conservative Management
•US Confirmation ( 88.78)
•Bedrest
•Tocolytic
•Lung Maturation
•LSCS (74.1)
•LSCS (74.1)
•Tubal ligation (66.39)
•LSCS (74.1)
•Pomeroy tubectomy (66.39)
ent ( 89.09)
GA followed Placenta was delivered completely
/9 FT AGA
m, diameter 18x17 cm
GA followed Placenta was delivered completely
meter 12x11 cm
abdominal termination
m, dimeter 10x12 cm
m, diameter 20x21 cm
GA , Imperforate anus
8 cm, diameter 20x21 cm
A/S 8/9 FTAGA
32 cm, diameter 22x19 cm
2 08 Januari 2021
3 08 Januari 2021
4 12 Januari 2021
FERTILITY AND ENDOCRINOLOGY OUTPATIENT REPORT
Friday, January 08th 2021
No. Bulan Tanggal
1 Januari 08 Januari 2021
2 08 Januari 2021
3 08 Januari 2021
4 08 Januari 2021
2 11 Januari 2021
3 13 Januari 2021
2 14 Januari 2021
Identitas
Mrs.EVI/48 yo/1194635/P2A0/ PRABUMULIH/ IJA-IS
Mrs. SIT/55 yo/1194636/ P1A0/PALEMBANG/IJA-IS
Ms. SHA/17 yo/1194676/ P0A0/ PALEMBANG/ IJA-HE
Identitas
Mrs. WUL/ 32 YO/ 1194326/ PALEMBANG/ P0A3/ ARM-AC
Identitas
Mrs. NET/ 38 yo/ 1191709/ BANYUASIN/WAH-RS P1A1
Identitas
Mrs. WIN/ 22 YO/ 1161537/ BANYUASIN/ P0A0/ ARM-AW
Mrs. NOP/ 36 YO/ 1095043/ P0A0/ PALEMBANG/ ARM-AC
Identitas
Mrs. FIT/ 37 YO/ 1144485/ PALEMBANG/ ARM-AW
Mrs. NIN/25yo/0941540/P0A/Banyuasin/WAH-AA
Identitas
Mrs.NYA /33 yo/774236/ P2A0/PALEMBANG/ARM
Identitas
Mrs. RUS/ 62 YO/ 1194700/ OGAN ILIR / P6A0/ IZY-RK
Identitas
Mrs.PON/ 58 YO/ 1194934/ KALIDONI / P8A0/ IZY-DES-HD
Identitas
Mrs. LES/ 41 YO/ 1194557/ PRABUMULIH/ P3A0/ FES-AT
Mrs. JUM/ 50 YO/ 1190062/ MUARA ENIM/ P0A0/ FES-IS
Mrs. IRM/ 40 YO/ 1070701/ PALEMBANG/P1A0/ FES-IS
Mrs. PRI/ 29 YO/ 720006/ PALEMBANG/ P3A0/ FES-RS
Mrs. RUB/ 69 YO/ 1195492/ PAGAR ALAM/ P3A0/ FES-RS
Mrs. ERL/ 61 YO/ 1038549/ INDRALAYA/ P2A0/ FES-RS
Mrs. ELL/ 69 YO/ 1186237/ PALEMBANG/ P6A1/ CYN-IS
Mrs. PON/ 50 YO/ 1193031/ OGAN KOMERING ULU/ P4A0/ FES-AT
Mrs. SUY/ 61 YO/ 1192314/ PALEMBANG P6A0/ FES-IS
Mrs. SUW/ 44 YO/ 1195476/ BANYUASIN P4A1/ FES-RS
Mrs. PAT/ 38 YO/ 1157081/ MUSI RAWAS/ P2A1/ FES-AT
Mrs. MAS/ 43 YO/ 1188488/ OGAN ILIR/ P3A1/ CYN-IS
Mrs . LIN/ 47 YO/ 1190432/ BANYUASIN/ P2A0/ FES-IS
Mrs. ROO/ 76 YO/ 1183709/ PALEMBANG/ P3A0/ FES-IS
Mrs. NUR/ 32 YO/ 1194679/ OKU TIMUR/ P2A0/ FES-IS
Mrs. HEN/ 43 YO/ 1189670/ OGAN KOMERING ILIR/ P3A0/ FES-RS
Mrs. RUM/ 42 YO/ 1189719/ PALEMBANG/ P4A1/ FES-RS
Miss. IDA/ 38 YO/ 1185408/ PALEMBANG/P0A0/ FES-IS
Mrs. WAR/ 53 YO/ 1189178/ LUBUK LINGGAU/ P3A0/ FES-IS
Mrs. ROD/ 33 YO/ 1185094/ RIAU/ P2A1/ FES-IS
Mrs. SAR/ 56 YO/ 1107553/ PALEMBANG/ P3A1/ FES-IS
Identitas
Mrs. NIL/
TJO/ 47 12365432/
61 YO/ YO/ 1210137/ OKU Selatan/ P1A0/ DID-IS
Sekayu/
DID-IS
Miss. NOV/ 20 YO/ 1233712/ Palembang/ P0A0/ DID-AT
Mrs. NUR / 52 YO/ 1235534/ Bangka Belitung/ DID- IS
TEM/ 51 YO/ 1229788/ Muara Enim/
P3A0/ DID-AT
Mrs.
FIT/
Mrs. 42 YO/451212052/
TAT/ Palembang/
YO/ 1208271/ P3A0/P2A1/
Palembang/ DID-RS
DID-IS
Mrs.
TAR/AIS/
Mrs. 41 YO/ 1115243/
64 YO/ Palembang/
1235044/ P2A0/
Palembang/ DID-AT
DID- RS
Mrs. MIL/OKU/
1231697/ 37 YO/ 1208971/ Musi Banyuasin/ P0A0/ RAM-HE
P3A0/OGL/HD
12314253/ PALEMBANG/ P2A0/OGL/AF
Mrs.
MUD/ 53 YO/
1234890/
MUSI RAWAS/ P2A0/OGL/AF
Diagnosa
Abnormal uterine bleeding caused by MI was suspected
Abnormal uterine bleeding caused by uterine adenomyosis wa
left cystic ovarian neoplasm
Diagnosa
Recurrent pregnancy loss
Endometriosis cyst was suspected
Dysmenorrhea caused by endometriosis cyst was suspected
Endometriosis cyst was suspected
Uterine adenomyosis diffuse type was suspected
Endometriosis grade III (ASRM Score 28 EFI Score 4)
Post laparoscopy myomectomv on indication uterine myoma Pos
Post salphingoraphy
Bilateral patent tube
Diagnosa
dysmenorrhea cb bilateral endometrial cyst was suspected
uterine Adenomyosis
internal genitalia organ adhesion
post leuprolide acetate injection 2nd series
Endometriosis grade III (ASRM Score 16)
post leuprolide acetate injection 5th series
Diagnosa
Right endometriosis cyst was suspected
Post multiple adenomyosis resection per laparoscopy
Diagnosa
Endometriosis ASRM grade IV ( ASRM score 120 + EFI Scor
Uterine adenomyosis
Bilateral patent tube
Endometriosis ASRM grade IV (ASRM Score 66 EFI score 7
Uterine adenomyosis
Post adhesiolysis oi Internal genitalia organ adhesion
Post bilateral salphingography
Patent tubes bilateral
Post leuprolide acetate 3.75 1st serie
Uterus myomatosus was suspected
Primary infertile 1 year
Diagnosa
Endometriosis ASRM grade IV
Post laparoscopy cystectomy bilateral
Post adhesiolysis bilateral as indication of internal genitalia organ adhesion
Tuba bilateral
Uterine adenomyosis
Subserous uterine myoma
Diagnosa
Cystocele grade III
Uterine prolapse grade IV
Rectocele grade III
Hypertension stage II
Diagnosa
Cystocele grade IV
Uterine prolapse grade IV
Rectocele grade II
Hypertension stage II
Polycystic right kidney
Diagnosa
Cervical cancer Stage IIA
Ovarian cancer Stage IIIC
Ovarian cancer Stage IIIC ( complete therapy complete respo
LGSIL
Solid ovarian neoplasm with malignancy was suspected
dd/ non-gynecology
Endometrial mass
cancer inadequate staging
Cervical cancer Stage IIIB
Cervical cancer Stage IIIB
Cervical cancer Stage IIIB
Stage IIIB was suspected AKI stage V was suspected
Moderate anemia
Ovarian cancer Stage IIIB
Endometriosis
GTN Stage I FIGO Score 2
GTN stage II FIGO Score 8
Endometrial cancer Stage IB ( endometrioid carcinoma FIGO
Endocervical polyp
Stage IIIB
Ovarian cancer Recurrent
Ovarian cancer Stage IC
Sage I FIGO Score 4
Stage IV FIGO Score 2
Left mucinous cystic ovarian neoplasm
Chronic hepatitis B
Stage IIIB
Recurrent
Moderate anemia
Stage IIA2
Stage IIIB.( complete therapy)
Severe anemia
Leukocytosis
AKI stage III was suspected
Hyponaremia
Hyperkalemia
Stage IIIB
Severe anemia
Hypoalbuminemia
Stage IIIB
Stage IIIB
Stage IIIB
Moderate anemia
Recurrent
Stage IA
Stage IC
Stage IIIC
Moderate anemia
Leucopenia
Cervical cancer
Ovarian cancer
Endometrial cancer
GTN Stage I FIGO Score 1
ASCUS
Cystic ovarian neoplasm with solid part malignancy was suspected
Moderate anemia
GTN
Ascites on cystic ovarian neoplasm with solid part malignancy was suspected
Cervical cancer
Ovarian cancer
GTN
GTN
Solid ovarian neoplasm was suspected
Cervical cancer
Endometrial cancer
GTN
Bilateral solid ovarian neoplasm with malignancy was suspected
Ascites
Intra-abdominal cystic mass was suspected dd/ mucinous cystic ovarian neoplasm was suspected
Cervical cancer
Ovarian cancer
Endometrial cancer
GTN
GTN
Cervical cancer
GTN
Solid ovarian neoplasm with malignancy was suspected ( C56)
Cervical cancer
Ovarian cancer
GTN
Cervical cancer
Ovarian cancer
GTN
Ovarian cancer(C56.9)
GTN (O01.9)
Cervical cancer (C53.9)
Cervical cancer (C53.9)
Ovarian cancer
GTN
Cervical cancer
Ovarian cancer
GTN
Cervical cancer
Ovarian cancer
GTN
Cervical cancer
Cervical cancer
Ovarian cancer
Endometrial cancer
Cervical cancer
Ovarian cancer
Ovarian cancer
GTN
Post hydatidiform mole evacuation ( O01.9)
Endometrial cancer
Cervical cancer
Ovarian cancer
GTN
Cervical cancer
Ovarian cancer
Endometrial cancer
Cervical cancer
Ovarian cancer
Ovarian cancer
Endometrial cancer
GTN
Cervical cancer
GTN
Ovarian cancer
Ovarian cancer
Ovarian cancer
Cervical cancer
Cervical cancer
Ovarian cancer
Endometrial cancer
Cervical cancer
Ovarian cancer
GTN
Cervical cancer
Ovarian cancer
GTN
Cervical cancer
Ovarian cancer
Endometrial cancer
GTN
Cervical cancer
Cervicalcancer
Ovarian cancer
Endometrial cancer
GTN
Cervical cancer
Ovarian cancer
Endometrial cancer
GTN
Cervical cancer
Cervical cancer
Ovarian cancer
Endometrial cancer
Cervical cancer
GTN
Ovarian cancer
Cervical cancer
Ovarian cancer
Endometrial cancer
Cervical cancer
Ovarian cancer
Ovarian cancer
Endometrial cancer
GTN
Uterine sarcoma was suspected ( C51.9) )
Cystic ovarian neoplasm with malignancy was suspected (C56)
Leimyosarcoma dd/ mesentrium tumor ( C56)
Cervical cancer
Ovarian cancers
Cystic ovarian neoplasm with maliganncywas suspected ( C56.9)
Uterine sarcoma was suspected ( C51.9)
AKI stage
Diagnosa
Ovarian II DD/Inadequate
cancer, acute on CKD stage
staging V (N13.02)
( C56.9)
Thrombocyotopenia ( D69.6)
Thrombocytopenia ( D69.6)
•Dysmenorrhea
Bilateral caused by bilateral endometriosis cyst was su
patent tube
Cervical cancersinistra
Labia mayora stage IV A was suspected
tumors
Rectocele grade II
Vagina Septum Incomplete
Prosedur
Laboratory examination
Plan for operative laparoscopy
Operative laparoscopy
Plan for operative laparoscopy
Prosedur
Inj. Leuprolide acetate 3.75 mg 3rd series
CaCo3 1tab/24 hours
Re-evaluation after 3rd series
Laparotomy myomectomy
Prosedur
Inj. leuprolide acetate 3.75 mg 2nd series
Prosedur
Laboratory examination
US confirmation
Consult internal medicine and anesthesiology department
Plan for total vaginal hysterectomy, colporrhaphy anterior and posterior
Prosedur
US confirmation
Consult to urology department
Consult internal medicine and anesthesiology department
Plan for total vaginal hysterectomy, colporrhaphy anterior and posterior
Prosedur
Plan for laparotomy radical hysterectomy
Chemotherapy paclitaxel-carboplatin 2nd course
Abdominal CT scan with contrast
Colposcopy
Internal medicine assessment
Abdominal CT scan with contrast
US gynecology
Chemotherapy paclitaxel-carboplatin 4th course
Chemotherapy paclitaxel-carboplatin 2nd course
radiotherapy paclitaxel-carboplatin
Plan for Chemotherapy
Plan for radiotherapy
Hospitalized
Internal
Plan for department assessment
Chemotherapy Paclitaxel-Carboplatin 2nd course
MR chemotherapy 4th course
MER chemotherapy 5th course
Plan for chemotherapy
Hysteroscopy DnC
Chemotherapy paclitaxel-carboplatin 3rd course
Plan for radiotherapy (March, 21st 2021)
diagnosis
Stage IIIB
Moderate anemia
Stage IIIB
Leucopenia
Stage IC
Stage IC ( complete therapy)
Stage IIIC
Moderate anemia
Recurrent
y was suspected
Stage IC
Mild anemia
Inadeqaute staging
Leucopenia
cy was suspected
cy was suspected
Stage IIIB
Mild anemia
Stage IIIB
Recurrent
Severe anemia
Stage IC
Moderate anemia
Stage IVA
Stage IA
Stage IA
Stage IIIC
Cancer pain
Stage IC
Was suspected
abdominal mass
y was suspected
Stage IB2
Stage IA ( C56)
Stage IA ( C56)
Thrombocytopenia ( D69.6)
pected ( C56)
pected ( C56)
Prosedur
PRC transfusion ( 99.04)
Chemotherapy paclitaxel-carboplatin 1st course ( 99.25)
Pap Smear’s Evaluation
Cefixime 200 mg/12 hours ( 99.1)
Chemotherapy pactliaxel-carboplatin1st course ( 99.25)
US gynecology ( March, 19th 2021)
Chemotherapy paclitaxel-carboplatin 3rd course ( 99.25)
Hospitalized
Leucogen injection ( 99.21)
MR Chemotherapy 1st course ( 99.25)
Hospitalized
Leucogen
US injection
gynecology ( 99.21)
( March, 19th 2021)
Planning for LEEP ( 67.32)
Planning for Laparotomy frozen section ( April, 05th 2021)
Plan for radiotherapy ( March, 18th 2021) ( 92.29)
Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)
Plan for radiotherapy ( 92.29)
PRC Transfusion ( 99.04)
BEP Chemotherapy 4th course ( 99.25)
Hospitalized
Laboratoryexamination
Laboratory examination((V72.62)
V72.62)
Chest-X-Raysurgical
Laparotomy ( 87.4) staging ( 54.29)
Laparotomy TAHBSO ( 54.2)
Hospitalized
Leucogen inj ( 99.21)
PRC Transfusion ( 99.04)
Chemotherapy paclitaxel-carboplatin 6th course ( 99.25)
Chemotherapy paclitaxel-carboplatin
Leucogen injection ( 99.21) 3rd course ( 99.25)
Chemotherapy paclitaxel-carboplatin 4th course ( 99.25)
MR chemotherapy 11th course ( 99.25)
Hospitalized
MER chemotherapy 9th course ( 99.25)
Hospitalized
MER chemotherapy 3rd course ( 99.25)
Hospitalized
Internal medicine
Laparotomy assessment ( 89.09)
VC ( 54.1)
Clinical staging
Urogynecology consultation ( 89.09)
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
Medicinalis ( 99.21)
Plan for radiotherapy (April, 28th 2021) ( 92.29)
PRC Transfusion ( 99.04)
Leucogen injection ( 99.21)
Laparotomy surgical staging ( 54.1)
Chemotherapy paclitaxel-carboplatin 3 course ( 99.25)
Laboratory examination ( V72.62)
US gynecology ( 88.79)
MR Chemotherapy 3rd course
Abdominal US examination ( 88.01)
Urology consult
Laparotomy VC (( 54.1)
89.09)
Sperm analysis (DNA fragmentation) (V26.21)
US examination during menstruation day 10th (88.7)
Plan for laparotomy total abdominal hysterectomy + bilateral salpingo-oophorectomy (68.49)
•Leuprolide acetate injection 3 more cycles (99.2)
•Sperm 2x5
Provera analysis
mg ( (V26.21)
14 days) ( 99.24)
Control ( when
Dienogest 2 mg/patient menstruation)
24 hours for 6 months ( 99.24)
US gynecology ( after 6 months therapy) ( 88.79)
Plan for diagnostic hysteroscopy operative laparoscopy
Plan for laparoscopy cystectomy ( 57.7)
•Plan for diagnostic hysteroscopy operative laparoscopy
Plan for diagnostic hysteroscopy operative laparoscopy
·Plan for Repair fistula
•Plan for laparotomy myomectomy (68.29- uterine myomectomy)
Hospitlized
Chemotherapy
PRC transfusionpaclitaxel-carboplatin
( 99.04) 1st course ( 99.25)
Plan for laparotomy surgical staging ( 99.25)
Tumor marker evaluation ( August, 09th 2021) (V72.16)
US evaluation ( 88.79)
Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)
ß-HCG evaluation ( April, 12th 2021) ( V72.4)
Chemotherapy MR 7th course ( 99.25)
Prosedur
Hysteroscopy DnC ( 68.12)
Internal medicine assessment à for DM treatment ( 89.09)
Laparotomy
Plan myomectomy
for laparotomy ( 68.29)
myomectomy
(68.29-
Plan uterine myomectomy)
for laparotomy hysterectomy bilateral salphingo-oophorectomy (68.29- uterine myomectomy)
Plan for PRC transfusion (99- transfusion of blood and blood component)
Laboratory examination (V72.62)
Medicinalis ( 99.2)
•Cortimoxasol 60 mg / 12 hours
Hospitalized
PRC transfusion
Chemotherapy ( 99.04)
paclitaxel-carboplatin 2nd course ( 99.25)
Plan for radiotherapy ( July,
Plan for radiotherapy (92.29) 02nd 2021) ( 92.29)
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
BEP Chemotherapy 3rd course ( 99.25)
Hospitalized
PRC transfusion
Chemotherapy ( 99.04)
paclitaxel-carboplatin 5th course ( 99.25)
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
Laparotomy VC ( 54.1)
Chemotherapy pacliltaxel-carboplatin 2nd course ( 99.25)
Pap’s smear ( V72.32)
Hospitalized
PRC transfusion
Tumor ( 99.04)(V72.4)
marker evaluation
Laboratory examination (V72.62)
Plan for CIM Chemotherapy ( 99.25)
Hospitalized
BEP chemotherapy 1st course ( 99.25)
Hosptialized
Leucogen
ß-HCG injection
evaluation ( 99.21)
(V72.3)
Plan laparotomy VC (54.1)
Plan for LEEP (68.12)
•Hospitalized
•Plan for
•Control inelective
1 week cesarean section (20.04.2021)
•Education
•CIE(E94.2)
•CIE
•Plan for consult Internal Medicine department
•CIE(E94.2)
•Antibiotic
•CIE
Prosedur
•Total vaginal hysterectomy (68.59)
•Anterior
•Repair of colporrhaphy
vaginal stump(70.51)
(70)
Inadequate staging
( C56.9)
Stage IIIB was suspected ( C53.9)
AKI
Stage IIIA (IIIC53.9)
Stage caused by uropathy obstructive ( N13.2)
Stage IVB ( C53.9)
Stage IIIB ( C53.9)
Stage IC (C56)
Leucopenia ( D72.819)
Stage IC ( C56)
Stage IIIC ( C56.9)
Stage IVA ( C54.9)
Stage IIIB ( C53.9)
Stage IIIC ( C53.9)
Complete
Stage IC ( therapy
C56.9)
Stage IVA ( C56.9) complete therapy
Stage IC ( C56.9)
Stage IC ( C54.9)
Stage II FIGO Score 6 ( O01.9)
pected (C56)
Prosedure
Laparotomy FS ( 54.1)
Hospitalized
TC Transfusion ( 99.05)
Chemotherapy pactliaxel-carboplatin 4th course ( 99.25)
Tumor marker evaluation ( V72.32)
Hysteroscopy D&C ( 69.02)
Chemotherapy paclitaxel-carboplatin 3rd course ( 99.25)
Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)
Laparoscopy hysterectomy ( 68.12)
Laparotomy FS (54.1)
Clinical staging
Plan for radiotherapy ( 92.29)
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Plan for radiotherapy ( 92.29)
CIM Chemotherapy 5th course ( 99.25)
Biopsy ( 70.24)
Laparotomy FS ( 54.1)
Laparotomy FS ( 54.1)
Laparotomy FS ( 54.1)
Radical hysterectomy ( 68.4)
Chemoradiation
Plan for branchytherapy ( 92.29)
Radical Hysterectomy
Chemotherapy paclitaxel-carboplatin 5th course
Labia mayor tumor resection ( 70)
Plan for husband’s sperm analysis
Control at menstruation
Re control at menstruation
Plan for HDLO
Plan for laparoscopy cystectomy
CaCO3 500mg/12 hours PO
Plan for SIS
DV assessment
•Laboratory examination
•MRI
•Chest X-ray
•Planfor
Plan forColphokleisis
Excision
Controlled when patient get menstruation
nd posterior
iagnosis
ingo-oophorectomy (68.49)
orectomy (68.29- uterine myomectomy)
od component)
(65.2), Adhesiolysis (614.6)
Cystoscopy
Clinical staging
Chemotherapy paclitaxel-carboplatin 2nd course
Hospitalized
PRC transfusion
Chemotherapy paclitaxel-carboplatin3rd course
Plan for radiotherapy (March, 22nd2020)
Chemotherapy paclitaxel-carboplatin 3rd course
Hospitalized
PRC transfusion
Hospitalized
PRC Transfusion
Chemotherapy paclitaxel-carboplatin 3rd course
Cefriaxone 1 gram/12 hours
Albumin 1 flash/24 hours
Plan for radiation ( 03rd March 2020)
Plan for radiation ( 03rd March 2020)
Chemotherapy paclitaxel-carb
Hospitalized
PRC Transfusion
Chemotherapy paclitaxel-carboplatin 3rd course
Chemotherapy paclitaxel-carb
Chemotherapy paclitaxel-car
BEP Chemohterapy 5th course
Hospitalized
PRC Transfusion
Leuocgen injection
Chemotherapy paclitaxel-carboplatin 3rd course
MER Chemotherapy 3rd course
Hospitalized
PRC transfusion
Radiotherapy
Hospitalized
Leucogen injection
Chemotherapy pactlixel-carboplatin 3rdcourse
Plan for radiotherapy ( March, 18th 2021)
Chemotherapy pactliaxel-carboplatin 5thcourse
Tumor marker evaluation
Hospitalized
PRC transfusion
Chemotherapy paclitaxel-carboplatin 2ndcourse
Laboratory examination
CIM Chemotherapy 1st course
Brachytherapy adjuvant 3x
Radiotherapy consult
MR Chemotherapy1st course
Colposcopy
Hospitalized
PRC transfusion
Plan Laparotomy surgical staging
Chemotherapy paclitaxel-car
Hospitalized
Leucogen injection
BEP 1st course
Plan for laparotomy surgical satging
MR chemotherapy 9th course
MR chemotherapy 9th course
MR Chemotherapy 1st course
Hospitalized
PRC transfusion
Chemotherapy paclitaxel-carboplatin 4th course
Plan for radiotherapy ( March, 21st2021)
Chemotherapy paclitaxel-carboplatin 6 course
Plan for radiotherapy
Chemotherapy paclitaxel-carboplatin 3rd course
Plan for radiotherapy ( March, 18th2021)
Hospitalized
PRC transfusion
Plan for radiotherapy simulation
Hospitalized
PRC transfusion
Chemotherapy paclitaxel-carboplatin 5th course
Hospitalized
PRC transfusion
TC transfusion
Leucogen injection
Chemotherapy paclitaxel-carboplatin 4th course
MR Chemotherapy 4th course
Laboratory examination La
Clinical staging
Pap’s smear
Chemotherapy paclitaxel- carboplatin 6 course
Plan for radiotherapy ( April, 27th2021)
Tumour marker evaluation
Laparotomy myomectomy
Laboratory examination
Chest-X-Ray
BNO-IVP
US gynecology
Hospitalized
PRC transfusion
Plan for radiotherapy Chemotherapy paclitaxel-carboplatin 6 co
Pap’s smear evaluation
Hospitalized
PRC transfusion
Chemotherapy paclitaxel-carboplatin 4th course
Plan for radiotherapy ( 09th February 2020)
Chemotherapy pacliraxel-carboplatin 3rd course
Laparoscopy surgical staging
Hospitalized
MER chemotherapy 3rd course
Laparotomy VC
Laparotomy VC
Abdominal CT Scan
Laparotomy VC
Hospitalized
CIM chemotherapy 4th course ( 99.25)
BNO-IVP ( 87.79)
Chest-X-Ray ( 87.4)
Clinical staging
BNO-IVP ( 87.79)
Chest-X-Ray ( 87.4)
Clinical staging
Laboratory examination ( V72.62)
Plan for radiotherapy ( 92.29)
Chemotherapy
aclitaxel-carboplatin 2nd course ( 99.25)
Plan for radiotherapy ( April. 19th 2021)
Chemotherapy paclitaxel-carboplatin 2ndcourse ( 99.25)
Hospitalized
Chemotherapy paclitaxel-carboplatin 2ndcourse ( 99.25)
TC transfusion ( 99.05)
Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)
Laboratory examination.( V72.62)
Hospitalized
Chemotherapy paclitaxel-carboplatin 3rdcourse ( 99.25)
TC transfusion ( 99.05)
Tumor marker evaluation ( V72.4)
MR chemotherapy 2nd course ( 99.25
MR chemotherapy 11th course ( 99.25)
MR chemotherapy 10th course ( 99.25)
Hospitalized
MER chemotherapy 2nd course ( 99.25)
5)
r 3 course of chemotherapy
clitaxel-carboplatin 2nd course
clitaxel-carboplatin3rd course
apy (March, 22nd2020)
clitaxel-carboplatin 3rd course
assessment
assessment
clitaxel-carboplatin 3rd course
py 5th course
ctlixel-carboplatin 3rdcourse
apy ( March, 18th 2021)
ctliaxel-carboplatin 5thcourse
clitaxel-carboplatin 2ndcourse
py 1st course
py1st course
surgical staging
my surgical satging
y 9th course
y 9th course
py 1st course
apy simulation
py 3rd course
al hysterectomy
py 2nd course
py 4th course ( 99.25)
nation ( V72.62)
apy ( 92.29)
uation ( V72.4)
2nd course ( 99.25
11th course ( 99.25)
10th course ( 99.25)
2 08 Januari 2021
3 08 Januari 2021
4 08 Januari 2021
5 08 Januari 2021
6 08 Januari 2021
7 08 Januari 2021
2 11 Januari 2021
3 11 Januari 2021
4 11 Januari 2021
5 11 Januari 2021
6 11 Januari 2021
7 11 Januari 2021
8 11 Januari 2021
9 11 Januari 2021
10 11 Januari 2021
No. Bulan Tanggal
1 Januari 12 Januari 2021
2 12 Januari 2021
3 12 Januari 2021
4 12 Januari 2021
5 12 Januari 2021
6 12 Januari 2021
7 12 Januari 2021
8 12 Januari 2021
No. Bulan Tanggal
1 Januari 13 Januari 2021
2 13 Januari 2021
3 13 Januari 2021
4 13 Januari 2021
5 13 Januari 2021
6 13 Januari 2021
7 13 Januari 2021
8 13 Januari 2021
9 13 Januari 2021
10 13 Januari 2021
11 13 Januari 2021
No. Bulan Tanggal
1 Januari 14 Januari 2021
2 14 Januari 2021
3 14 Januari 2021
4 14 Januari 2021
5 14 Januari 2021
2 08 Januari 2021
3 08 Januari 2021
4 08 Januari 2021
5 08 Januari 2021
6 08 Januari 2021
7 08 Januari 2021
8 08 Januari 2021
1 Januari 09 Januari 2021
2 09 Januari 2021
3 09 Januari 2021
4 09 Januari 2021
2 10 Januari 2021
3 10 Januari 2021
4 10 Januari 2021
5 10 Januari 2021
2 11 Januari 2021
3 11 Januari 2021
4 11 Januari 2021
5 11 Januari 2021
6 11 Januari 2021
7 11 Januari 2021
8 11 Januari 2021
9 11 Januari 2021
2 12 Januari 2021
3 12 Januari 2021
4 12 Januari 2021
5 12 Januari 2021
6 12 Januari 2021
7 12 Januari 2021
8 12 Januari 2021
no bulan tanggal
1 Maret 12.03.2021
2 Maret 12.03.2021
3 Maret 16.03.2021
4 Maret 18.03.2021
5 Maret 12.03.2021
6 Maret 12.03.2021
7 Maret 12.03.2021
8 Maret 12.03.2021
9 Maret 12.03.2021
10 Maret 12.03.2021
11 Maret 12.03.2021
12 Maret 12.03.2021
13 Maret 15.03.2021
14 Maret 15.03.2021
15 Maret 15.03.2021
16 Maret 15.03.2021
17 Maret 15.03.2021
18 Maret 15.03.2021
19 Maret 15.03.2021
20 Maret 15.03.2021
21 Maret 15.03.2021
22 Maret 15.03.2021
23 Maret 15.03.2021
24 Maret 16.03.2021
25 Maret 16.03.2021
26 Maret 16.03.2021
Maret 16.03.2021
Maret 16.03.2021
Maret 16.03.2021
Maret 16.03.2021
Maret 16.03.2021
Maret 16.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 18.03.2021
Maret 18.03.2021
Maret 18.03.2021
Maret 18.03.2021
Maret 18.03.2021
Maret 18.03.2021
Maret 12.03.2021
Maret 12.03.2021
Maret
Maret 15.03.2021
Maret
Maret
Maret 16.03.2021
Maret
Maret
Maret 17.03.2021
Maret
Maret 18.03.2021
Maret
Maret 15.03.2021
Maret 16.03.2021
Maret
Maret 17.03.2021
Maret
Maret
Maret
Maret 18.03.2021
Maret
Maret 15.03.2021
Maret
Maret 16.03.2021
Maret
Maret 17.03.2021
Maret
Maret
Maret 18.03.2021
Maret
Maret 12.03.2021
Maret
Maret
Maret
Maret 13.03.2021
Maret
Maret
Maret
Maret
Maret
Maret
Maret 14.03.2021
Maret
15.03.2021
16.03.2021
17.03.2021
18.03.2021
12.03.2021
15.03.2021
16.03.2021
17.03.2021
18.03.2021
12.03.2021
15.03.2021
16.03.2021
17.03.2021
18.03.2021
05.03.2021
08.03.2021
09.03.2021
10.03.2021
05.03.2021
08.03.2021
09.03.2021
10.03.2021
09.03.2021
05.03.2021
10.03.2021
05.03.2021
06.03.2021
07.03.2021
08.03.2021
09.03.2021
10.03.2021
08.03.2021
09.03.2021
15.03.2021
05.03.2021
05.03.2021
08.03.2021
09.03.2021
10.03.2021
05.03.2021
08.03.2021
09.03.2021
10.03.2021
19.03.2021
22.03.2021
23.03.12
24.03.2021
25.03.2021
19.03.2021
22.03.2021
23.03.2021
24.03.2021
25.01.2021
19.03.2021
No Bulan Tanggal
1 April 03.04.21
2 April 03.04.21
3 April 03.04.21
4 April 03.04.21
5 April 03.04.21
6 April 04.04.21
7 April 04.04.21
8 April 04.04.21
9 April 04.04.21
10 April 04.04.21
11 April 05.04.21
12 April 05.04.21
13 April 05.04.21
14 April 05.04.21
15 April 05.04.21
16 April 05.04.21
17 April 05.04.21
18 April 05.04.21
19 April 05.04.21
20 April 05.04.21
21 April 05.04.21
22 April 05.04.21
23 April 05.04.21
24 April 05.04.21
25 April 05.04.21
26 April 05.04.21
27 April 05.04.21
28 April 05.04.21
29 April 05.04.21
30 April 05.04.21
31 April 05.04.21
32 April 05.04.21
33 April 05.04.21
34 April 05.04.21
35 April 06.04.21
36 April 06.04.21
37 April 06.04.21
38 April 06.04.21
39 April 06.04.21
40 April 06.04.21
41 April 06.04.21
42 April 06.04.21
43 April 06.04.21
44 April 06.04.21
45 April 06.04.21
46 April 06.04.21
47 April 06.04.21
48 April 06.04.21
49 April 06.04.21
50 April 06.04.21
51 April 06.04.21
52 April 06.04.21
53 April 06.04.21
54 April 06.04.21
55 April 06.04.21
56 April 06.04.21
57 April 06.04.21
58 April 07.04.21
59 April 07.04.21
60 April 07.04.21
61 April 07.04.21
62 April 07.04.21
63 April 07.04.21
64 April 07.04.21
65 April 07.04.21
66 April 07.04.21
67 April 07.04.21
68 April 07.04.21
69 April 07.04.21
70 April 07.04.21
71 April 07.04.21
72 April 07.04.21
73 April 07.04.21
74 April 07.04.21
75 April 07.04.21
76 April 07.04.21
77 April 07.04.21
78 April 07.04.21
79 April 07.04.21
80 April 07.04.21
81 April 07.04.21
82 April 07.04.21
83 April 08.04.21
84 April 08.04.21
85 April 08.04.21
86 April 08.04.21
87 April 08.04.21
88 April 08.04.21
89 April 08.04.21
90 April 08.04.21
91 April 08.04.21
92 April 08.04.21
93 April 08.04.21
94 April 08.04.21
95 April 08.04.21
96 April 08.04.21
97 April 08.04.21
98 April 08.04.21
99 April 08.04.21
100 April 08.04.21
101 April 08.04.21
102 April 08.04.21
103 April 08.04.21
104 April 08.04.21
105 April 09.04.21
106 April 09.04.21
107 April 09.04.21
108 April 09.04.21
109 April 09.04.21
110 April 09.04.21
111 April 09.04.21
112 April 09.04.21
113 April 09.04.21
114 April 09.04.21
115 April 09.04.21
116 April 09.04.21
117 April 09.04.21
118 April 09.04.21
119 April 12.04.21
120 April 12.04.21
121 April 12.04.21
122 April 12.04.21
123 April 12.04.21
124 April 12.04.21
125 April 12.04.21
126 April 12.04.21
127 April 12.04.21
128 April 12.04.21
129 April 12.04.21
130 April 12.04.21
131 April 12.04.21
132 April 12.04.21
133 April 12.04.21
134 April 12.04.21
135 April 12.04.21
136 April 12.04.21
137 April 13.04.21
138 April 13.04.21
139 April 13.04.21
140 April 13.04.21
141 April 13.04.21
142 April 13.04.21
143 April 13.04.21
144 April 13.04.21
145 April 13.04.21
146 April 13.04.21
147 April 13.04.21
148 April 13.04.21
149 April 13.04.21
150 April 13.04.21
151 April 14.04.21
152 April 14.04.21
153 April 14.04.21
154 April 14.04.21
155 April 14.04.21
156 April 14.04.21
157 April 14.04.21
158 April 14.04.21
159 April 14.04.21
160 April 14.04.21
161 April 14.04.21
162 April 15.04.21
163 April 15.04.21
164 April 15.04.21
165 April 15.04.21
166 April 15.04.21
167 April 15.04.21
168 April 15.04.21
169 April 15.04.21
170 April 15.04.21
171 April 15.04.21
No Bulan
1 Juni
2 Juni
3 Juni
4 Juni
5 Juni
6 Juni
7 Juni
8 Juni
9 Juni
10 Juni
11 Juni
12 Juni
13 Juni
14 Juni
15 Juni
16 Juni
17 Juni
18 Juni
19 Juni
20 Juni
21 Juni
22 Juni
23 Juni
24 Juni
25 Juni
26 Juni
27 Juni
1 Juli
No Bulan
1 September
2 September
3 September
4 September
5 September
6 September
7 September
8 September
9 September
10 September
11 September
12 September
13 September
14 September
15 September
16 September
17 September
18 September
19 September
20 September
21 September
22 September
Identitas
Mrs. IRA/ 40 YO/ 1193029/ BANGKA BELITUNG/ P2A1/ CYN-AT
Identitas
Mrs. WID/ 41 YO/ 1192742/ PALEMBANG/P4A1/ CYN-IS
P2A1
VAI-TIA
Mrs. Kar/44yo/P1A0/
193490/Palembang/IS
TIA-VAI
IS
TIA-VAI
VAI-TIA
P3A0/ IS
VAI-TIA
TIA-VAI
VAI-TIA
TIA-VAI
VAI-TIA
TIA-VAI
VAI-TIA
TIA-VAI
TIA-VAI
VAI-TIA
VAI-TIA
VAI-TIA
TIA-VAI
VAI-TIA
TIA-VAI
VAI-TIA
TIA-VAI
VAI-TIA
TIA-VAI
TIA-VAI
VAI-TIA
DEV-OSP/
identitas
Mrs. HERDA
APRIYANI/ 37 YO/ 1194544/ MUARA ENIM/ P1A0/ STI-HAD/ AT
Mrs. FETRI
Miss. YENI/ 46
Ely Mulyani/ 49 YO/ 1200201/OGAN ILIR/ P5A0/ STI-HAD/ AT
1067226/ PALEMBANG/
STI-HAD-IS
Mrs. MIFTA PRATIWI/ 28 YO/ 1102433/ PALEMBANG/ STI-HAD/NS
Mrs. ELI/ 51 YO/ 1158879/ MUSI RAWAS/ P0A1/SAR-AT
Miss. HAM/ 21 YO/ 1190177/ MUSI RAWAS/ P0A0/ SAR-AT
Mrs. SAR/ 58 YO/ 1198813/ OKU TIMUR/ P0A1/ SAR-RS
Miss. ALA/ 48 YO/ 1104499/ PALEMBANG/ P0A0/ SAR-RS
Mrs. RUK/ 41 YO/ 1189789/ PRABUMULIIH/ P2A0/ IJA-IS
Mrs. LIN/ 48 YO/ 1190432/ PALEMBANG/ P2A0/ SAR-IS
Mrs. DEW/ 20 YO/ 1190997/ MUSI BANYUASIN/ P0A1/ SAR-AT
Mrs. NUR/ 64 YO/ 1102751/ PALEMBANG/ P5A2/ IJA-RS
Mrs. MUR/ 46 YO/ 1162745/ PALEMBANG/ P2A0/ MIQ-RS
Mrs. RUH/ 60 YO/ 1196750/ JAMBI/ P2A0/ MIQ-AT
Mrs. HAN/ 43 YO/ 1195022/ PRABUMULIIH/ P5A2/ MIQ-AT
Mrs. NUR/ 47 YO/ 11975921/ MUSI RAWAS/ P3A3/ MIQ-IS
Mrs. HAN/ 49 YO/ 1051669/ MUSI RAWAS/ P3A0/ MIQ-IS
Mrs. DEW/ 58 YO/ 1177951/ BENGKULU/P2A1/ MIQ-RS
Mrs. SHE/ 27 YO/ 1200079/ PALEMBANG/ P0A2/ MIQ-IS
Mrs. SUP/ 36 YO/ 1200078/ BANYUASIN/ P1A0/ MIQ-IS
Mrs. PAT/ 39 YO/ 1157081/ MUSI RAWAS/ P2A0/ MIQ-AT
Mrs. ELI/ 44 YO/ 1142806/ PALEMBANG/ P3A0/ MIQ-RS
Mrs. SUL/ 39 YO/ 1198965/ LAMPUNG/ P4A0/ MIQ-RS
Mrs. SUW/ 58 YO/ 116098/ OGAN KOMERING ILIR/ P4A0/ MIQ-RS
Mrs. MUL/ 49 YO/ 1200391/ EMPAT LAWANG/ P3A0/ MIQ-AT
Mrs. AGU/ 43 YO/ 1186285/ BANGKA BELITUNG/ P3A1/ MIQ-RS
Mrs. NIN/ 46 YO/ 1181583/ PALEMBANG/ P2A0/ MIQ-IS
Mrs. HIL/ 42 YO/ 1184822/ PALEMBANG/ P0A0/ MIQ-IS
Mrs. ERN/ 43 YO/ 1176021/ PALEMBANG/ P3A0/ MIQ-RS
Mrs. ANI/ 17 YO/ 174287/ PALEMBANG/ P0A1/MIQ-RS
Mrs. DAR/ 35 YO/ 232016/ PALEMBANG/ P4A0/ MIQ-RS
Mrs. TIA/ 24 YO/ 1184535/ OGAN ILIR/ P0A1/ MIQ-IS
Mrs. CIK/ 61 YO/ 1199981/ MUARA ENIM/ P7A3/ MIQ-IS
Mrs. NUR/ 50 YO/ 1157496/ BANYUASIN/ P1A0/ MIQ-AT
Mrs. SIT/ 69 YO/ 1199680/ MUARA ENIM/ P2A0/ MIQ-IS
Mrs. ROS/ 62 YO/ 1186276/ PALEMBANG/ P6A0/ MIQ-AT
Mrs. LIN/ 40 YO/ 1140853/ LUBUK LINGGAU/ P2A0/ MIQ-IS
Mrs. MAS/ 44 YO/ 1198554/ BANYUASIN/ P4A0/ MIQ-AT
Mrs. GUS/ 48 YO/ 1182780/ PALEMBANG/ P3A0/ MIQ-IS
Mrs. SUS/ 32 YO/ 1200552/ MUARA ENIM/ P3A0/ MIQ-AT
Mrs. SHE/ 29 YO/ 1192096/ PALEMBANG/ MIQ-AT
Mrs. NOV/ 26 YO/ 1197552/ EMPAT LAWANG/ P2A0/ MIQ-AT
Mrs. ASN/ 56 YO/ 1200417/ PALEMBANG/ P4A0/ MIQ-IS
Mrs. MAR/ 57 YO/ 846749/ P1A0/ MIQ-AT
Mrs. NOR/ 55 YO/ 1198795/ JAMBI/ P5A0/ MIQ-AT
Mrs. RUM/ 42 YO/ 1189719/ PALEMBANG/ P4A1/ MIQ-RS
Mrs. TUR/ 56 YO/ 1199031/ PRABUMULIH/ P1A0/ MIQ-RS
Mrs. YUS/ 52 YO/ 1192268/ BANGKA BELITUNG/ P3A0/ MIQ-IS
Mrs. HER/ 52 YO/ 1074388/ PALEMBANG/ P3A0/ MIQ-RS
Miss. MAR/45
Mrs. TAR/ 24YO/
YO/1200069/
1200645/PALEMBANG/
PALEMBANG/P0A0/
P0A0/OSP-HE
MIQ-IS
Mrs. WHI/ 39 YO/ 1055047/ PALEMBANG/ P2A0/ OSP-HE
Mrs. NAD/36 YO/ 1199886/ Palembang/ P0A0/ OSP-HE
Mrs. KOM/ 33 YO/ 1200206/ Banyuasin/ P0A3/ OSP-MUG-AW
Mrs. END/ 38 YO/ 1200053/ Muara Enim/ P0A0/ OSP-MUG-HE
Mrs. IKA/ 33 YO/ 1185297/ OKU/ P2A0/ CYN-MUG-KY
Mrs. MAR/ 39 YO/ 1200339/ Palembang/ P0A0/ CYN-HE/FU
Mrs. ANI/35 YO/ 1191628/ Palembang/ P0A0/ CYN-IZ/FU
Mrs. Umi Kalsum/38 YO/ 1166910/ Muara Enim/ P1A0/ CYN-AA/FU
Mrs. ROS/ 38 YO/ 1200378/ Musi Rawas/ P1A0/ CYN-IZ/HE
Ms. YEN/29 YO/ 1158287/OKU/ P0A0/ CYN-AW/FU
Mrs. SIT/ 40 YO/ 1183209/ BANYUASIN/ P2A0/ OSP-AW
Mrs. YEN/ 33 YO/ 117989/ MUARA ENIM/ P0A0/ OSP-HE
Mrs. HAS/ 55 YO/ 1165582/ MUSI RAWAS/ P5A2/ HD –SAR – HIL
Mrs. TIN/ 17 YO/ 1170956/ Kertapati/ P0A0/ HD –SAR – HIL
Mrs. SUP/ 76 YO/ 1190695/ Prabumulih/ P7A0/ AF –SAR – HIL
Mrs. NUR/ 63 YO/ 1198547/ PALEMBANG/ P4A0/ RK-HIL-SAR
Mrs. RIH/ 54 YO/ 1194072/ Palembang/ P4A0/ RK- SAR - HIL
Miss RIA / 2 YO / 1200617 / Musi Banyuasin / HD – SAR – HIL
Mrs. Lia Sagita/ 36 YO/ 1200434/ PALEMBANG/ SAR-HD
Mrs.FET/
Miss. CHE46/ 9YO/
YO/1200201/OGAN
1170956/ Musi ILIR/
Rawas P5A0/AT-HD-SAR-HIL
/ P0A0 / FU- HD – SAR - HIL
MRS. EVI/ 39 YO/ 90908/ Palembang/ P4A0/ IZY-AA/ NS
MRS. YEN/ 40 YO/ 936444/ Palembang/ P1A0/ IZY-AT/ NS
Mrs. ELL/52 YO/ 722842/ Palembang/ P3A2/ IZY-IS/ HD
Mrs. MAL/ 53 YO/ 1199130/ Banyuasin/ P4A0/ WIS-RS/ HD
Mrs. NUR/ 41 YO/ 1168304/ Palembang/ P1A0/ IZY-IS/ RS
Mrs. ELI/ 33 YO/ 1200538/ Palembang/ P2A0/ IZY-HD/ RS
Mrs. NAN/ 48 YO/ 1200425/ Palembang/ P5A1/ IZY-NS/ RS
Mrs.Ros/70YO/1200853/Lubuk-linggau/STI-ARM/ RS
Mrs.Neli
Mrs. Openi/46YO/
WIL/41 1200842/STI-ARM/RS
YO/1193462/Prabumulih/P0A1
Mrs. DEW/21 YO/1197704/Muara Enim/P1A0
IZY/ AT-HE
Miss. HAM/ 21 YO/ 1190177/ MUSI RAWAS/ P0A0/ SAR-AT
Mrs.EMI/40YO/1184667/STI-HIL/IS
Mrs.ITA/29YO/
1200256/Ogan-ilir/STI-HIL/AT
Mrs.ROG/63YO/139064/Ogan Ilir/STI-HIL/
Mrs. MEL/40 YO/355585/Palembang/P1A0
Mrs. EMI/39 YO/1196412/Bengkulu/P2A0/AF-HD
HIL-SAR
Mrs. REN/ 49 YO/ 948571 / Banyuasin/ P3A1 / MUG-IS
Mrs. RUS/ 38 YO/ 1194105 / Banyuasin/ P0A0 / MUG-KY
Mrs. FEB/ 30 YO/ PALEMBANG/ DID-UFA/ AB
Mrs. LIL/ 32 YO/ PALEMBANG/ DID-UFA/ AT
Mrs. HOL/
ROM/52
60YO/
YO/1196156/
1167298/PALEMBANG/DEV-IZY/
PALEMBANG/ ZAN-UFA/ ISIS
Mrs. RUS/ 38 YO/ 1194105 / Banyuasin/ P0A0 / MUG-KY
Miss. REG 23 YO/ 1199114/ PALEMBANG/ IJA-IS
UTI
WIS-TIA
Mrs. RIH_x000B_54 YO_x000B_1194072_x000B_Palembang_x000B_P4A0_x000B_RK-THR
UTI
VAI
UTI
VAI
UTI
VAI
URI
TIA
UTI
TIA
WIS
AT HE
UTI
TIA
VAI USW/ 33 YO/ 1185834/ Palembang/ P0A0/ CYN-AW
Mrs.
FES
Mrs. VER/ 42 YO/ 1197277/ Banyuasin/ P0A0/ CYN-IS
Mrs.
IJA SOF/ 38 YO/ 1199843/ PALEMBANG/MIQ-INO-ZAN/ AF
AF-HD
SAR-HIL
RK-HD
SAR-HIL/TIA
VAI
IJA
KY-AT
IJA
VAI
IJA
VAI
IJA
VAI
IJA
TIA
IZY
IJA
Digestive division
FB
IZY
RS
UTI
Mrs. DEW/ 32 YO/ 1199652/ Palembang/ CYN-RS
Mrs. SIT/ 33 YO/ 1199903/P0A0 Palembang/ HE-AT
Mrs. BEL/ 28 YO/ 1199666/ Palembang/ RS
Mrs. SAH/ 42 YO/ 1199710/ Palembang/ CYN-IS
Mrs. END/ 38 YO/ 1200053/ Muara Enim/ HE-AT
Mrs. ROS/ 38 YO/ 1200378/ Palembang/ AW-AA
Mrs.
WIS KOR/ 29 YO/ 1200818/ Palembang/ CYN-IS
THR
FB
WIS
AF-HD
SAR-HIL
RK-HD
SAR-HIL
FB
IZY
RS
UTI
Identitas
Mrs.OVI/22 YO/1202426/ PALEMBANG/ DEV-HIL/ FY
Mrs. MAR/ 39 YO/ 1200339/ Palembang/ AT-HE
Mrs. EFE/ 40 YO/ 1113077/ Palembang/ RK-AC
Mrs. MAR/ 61 YO/ 1201232/ Muara Enim/ P3A0/ AF-HD/ ARM
Mrs. MAY/ 51 YO/ 1200336/ Bangka Belitung/ P2A0/ AT-HE/ MUT
Mrs. HAB/ 31 YO/ 1202444/ PALEMBANG/API-UFA/ HE
Mrs. YUL/43
YOH/ 32YO/1154499/Palembang/P2A0/
YO/ 1202574/P2A2 PALEMBANG/IJA-KOM/RS
STI-TIA/ AB
Mrs. RIS/ 38 YO/ 1201546/ Palembang/ P0A0/ IS/ MUT- IJA
Ms. PUS/ 49 YO/ 1195265/ Ogan Komering Ilir/ P1A0
Mrs. DWI 48 Y/ 1202529/ Palembang/ P2A0 / RS/ MUT-IJA
Mrs. DAN/ 33 YO/ 880133/ Palembang/ NAL-AW-AT
Mrs.MAY/51
Mrs. MAR/61YO/1200336/Bangka
YO/1201232/ Muara Belitung/P2A0/MUT/AT-HE
Enim/P3A0/AF-HD/ARM
EMY/ 49
Mrs. HER/ 35 YO/ 1195510/
1202580/ PALEMBANG/
OGAN ILIR/P2A0/ MIQ-RS
P5A2/ MIQ-IS
Mrs. LIS/ 33 YO/ 1184883/ Banyuasin/ CYN-IS/AW
Mrs. ROS/ 38 YO/ 1200378/ P1A0/ Musi Rawas/ CYN-AW/AW
Mrs. UMI/ 38 YO/ 1166910/ Muara Enim/ AW-AA
Mrs. IND/ 30 YO/ 1194937/ Banyuasin/ P0A3/ CYN-FU/ FU
Mrs. Sri/ 28 YO/ 1202560/ Palembang/ P4A0/ CYN-KY/ KY
Mrs. YUL/43
YOH/ 32YO/1154499/Palembang/P2A0/ IJA-KOM/RS
YO/ 1202574/P2A2 PALEMBANG/ STI-TIA-VAI/ AB
Mrs. ROH/ 66 YO/ 1201232/ OKU TIMUR/ P3A0/ RK-SAR-ARM
Mrs. ASM/48 YO/ 921541/ Palembang/ P2A0/ HD/ SAR-ARM
Mrs. MAR/ 29 YO/ 1194662/ Palembang/ P1A0/ RK/ SAR-ARM
Mrs. RIT/ 44 YO/ 865235/ BANYUASIN/ P2A1/ OSP-RS
KAR/ 23 YO/ OGAN KOMERING ILIR/ INO - CYN / AF - RK
Miss. LIL/
MRS. YUL/3943YO/
YO/1201331/
1202309/Palembang/
Palembang/P0A0/
P2A0/HE
HE– –HIL
HIL
Mrs. MAR/ 64 YO/ 1202790/ BETUNG/ P5A0/ HD / SAR-ARM
Mrs. EMI/ 43 YO/ 942357/ Lahat/ P3A0/ AF/ SAR-ARM
Mrs. MUR/ 41 YO/ 1202831/ Sekayu/ P2A0/ HD/ SAR-ARM
Mrs. DAN/ 33 YO/ 880133/ Palembang/ NAL-AW-AT
Mrs. RIS/ 38
Ms. PUS/ 49 YO/ 1201546/
1195265/ Palembang/ P0A0/
Ogan Komering Ilir/MUT-IJA/ IS
P1A0 / MUT-IJA/ RS
Mrs. DWI / 48 YO/ 1202529/ Palembang/ P2A0 / MUT-IJA/ RS
Mrs.
KAR/RIS/ 33 YO/
23 YO/ OGAN1200607/ Palembang/
KOMERING AT-HE
ILIR/ INO - CYN / AF - RK
Mrs. NIS/ 57 YO/ 1202985/ OKU/ P5A0/ RK / SAR-ARM
Mrs. IRM/ 46 YO/ 1183676/ Muara Enim/ P3A0/ AF-RK/ SAR-ARM
Miss. DIA/ 17 YO/ 1134439/ PALEMBANG/ HIL-PM
Miss. ZAH/ 32 YO/ 1090862/ PALEMBANG/ HIL-RS
LANASARI BINTI
Mrs. MUDRIKAH BINTISYAFIK/
ASNAWI/3435YO/
YO/OGAN
MUSIILIR/ KOM/ PMKOM/AB
BANYUASIN/
Mrs. ROI/
Miss. FIT/ 34
46 YO/
YO/ 1202550/P3A0/ Palembang/ AT-HE
1203312/OKU TIMUR/JAY-API-VAI-TIA/ AT
Mrs. DAR / 38 YO/ 1197642/ Palembang/ P0A0/ AT-HE/ MUT-RAM
Ms. UNA/ 43 YO/ 1002161/ PALEMBANG / P1A0 / RS/ FES-RAM
Mrs. EMI/43 YO/942357 / Lahat/ P3A0/ AF-MIQ
Mrs. DER/ 33 YO/ 805564/ Palembang/ NAL-HE-AT
Mrs. SIT/ 43 YO/ 1201694/ OKU TIMUR/ P0A0/ KY-AT/ MUT-RAM
Ms. KAI/ 18 YO/ 1198667/ BENGKULU/ P0A0/ AA-AT/ MUT
Mrs. KOM/ 49 YO/ 1203021/ OGAN KOMERING ULUR TIMUR/ P4A0/ ZAN-AT
Mrs. VIN/ 36 YO/ 1200442/ MUSI BANYUASIN/ P3A0/ ZAN-AT
Mrs. ZAH/ 56 YO/ 1203475/ JAMBI/ P5A0/ ZAN-RS
Mrs. NIN/ 46 YO/ 1181583/ PALEMBANG/ P2A0/ UTI-IS
Miss. KHA/ 24 YO/ 1200690/ LAMPUNG/ P0A0/ UTI-IS
Mrs. SUG/ 61 YO/ 1193704/ PALEMBANG/ P1A0/ MIQ-RS
Mrs. YUL 43 YO/ 1203585/ OGAN KOMERING ILIR/ UTI-RS
Tanggal
02.06.21
03.06.21
04.06.21
04.06.21
10.06.21
10.06.21
10.06.21
11.06.21
04.06.21
04.06.21
07.06.21
09.06.21
10.06.21
08.06.21
08.06.21
10.06.21
11.06.21
11.06.21
11.06.21
11.06.21
11.06.21
11.06.21
11.06.21
11.06.21
12.06.21
13.06.21
14.06.21
Tanggal
27.08.21
28.08.22
29.08.22
30.08.22
31.08.22
01.09.22
Diagnosa
Cervival Cancer
Ovarian Cancer
Endometrial cancer
Diagnosa
Cervical Cancer
Ovarian Cancer
Endometrial cancer
GTN
Left mature teratoma was suspected
Diagnosa
Cervical Cancer
Ovarian Cancer
Endometrial cancer
Post laparotomy total hysterectomy on indication GTN Stage I FIGO Score 6
Thrombocytosis
Right pleural effusion
Cystic ovarian neoplasm with solid part malignancy was suspected
Diagnosa
Cervical Cancer
Ovarian Cancer
GTN
Uterine sarcoma FIGO grade I
GTN
Cervical cancer
Pre-operative diagnosis
Post operative diagnosis
Pre-operative diagnosis
Pre-operative diagnosis
· Blighted Ovum
· COVID-19 was suspected (Ig G reactive)
Incomplete abortion
Pre-operative diagnosis
Post operative diagnosis
Pre-operative diagnosis
Post operative diagnosis
Pre-operative diagnosis
Pre-operative diagnosis
Post operative diagnosis
Pre-operative diagnosis
Pre-operative diagnosis
Post operative diagnosis
Pre-operative diagnosis
Post operative diagnosis
Pre-operative diagnosis
· Death conceptus
· Covid-19 was suspected ( IgG and IgM reactive)
Cervical cancer
Pre-operative diagnosis
Post operative diagnosis
Pre-operative diagnosis
Post operative diagnosis
· Incomplete abortion
· Covid-19 was suspected
Ovarian cancer
Cervical cancer
Pre-operative diagnosis
Post operative diagnosis
Pre-operative diagnosis
myometrium, endometrium
Unspecified ovarian cyst
endometriosis of fallopian tube
Malignant neoplasm ovary
Intramural leiomyoma of uterus
Intramural leiomyoma of uterus
hypoplasia
• Grossofhematuria
uterus caused by infiltration mass was suspected
• AKI Stage III
• Moderate anemia
• hypoalbuminemia
Bilateral endometriosis cyst
inadequate
Ovarian cancer stage staging therapy
IIC complete ( C56.9 ( C56.9)
Ovarian cancer stage IC ( C56.9)
GTN Stage I FIGO Score 8 (O01.9)
GTN Stage I, FIGO Score 3 ( O01.9)
Leukocytosis ( 288.19)
Cervical cancer Stage IIB ( Complete therapy) (C53.9 )
Cervical cancer Stage IIIB ( C53.9)
Cervical cancer Stage IIA2 (C53.9)
Cervical cancer Stage IIIB complete therapy ( C53.9)
Cervical cancer
Leucopenia Recurrent ( C53.9)
( D72.819)
Cervical cancer Stage IIA was suspected ( C53.9)
Ovarian
Post cancer Inadequate staging ( C56)
DJ Stent
Controlled hypertension (I10)
Hematuria c.b bladder tumor was suspected (C67.9)
Intramural
Secondaryuterine
infertilemyoma
1 year (dd/ adenomyoma ( D25.1
N97.9)
Infetile primer 8 years ( N97.9)
Moderate anemia (
Primary infertile7 years ( N97.9)
Endometriosis ASRM Grade III (ASRM Score 32, EFI Score 8) (N80.1)
Primary infertile 3 years (N97.9)
Primary infertile 10 years (N97.9)
Internal genitalia adhesion (N97.9)
Secondary infertile 12 years (N97.9)
Chronic disease
Cervical cancer
Ovarian cancer
Bilateral salpingo-oophorectomy
Post adhesiolisis o.i adhesion with omentum, peritoneum, intestine
Post laparotomy right cystectomy on indication right tubo ovarian abcess.
Post left salpingo-oophorectomy on indication left cyst ovarian
Solid ovarian neoplasm with malignancy was suspected dd/ intra-abdominal mass non-gynecology
Icteric caused by hepatobilier obstruction ; liver metastases
Left hydronephrosis
Thrombocytopenia
Post adhesiolysis on indication internal genital adhesion
Solid ovarian
-Cystic neoplasm
ovarian (D27.9
neoplasm with solid part papillary, malignancy was suspected
Leukopenia ( D72.819)
GTN was suspected ( O01.9)
LGSIL ( genital
Internal R87.613)
adhesion ( N73.6)
Uterine adenomyosis
Ovarian cancer inadequate staging
Cervical cancer stage IB2
Multilocular cystic ovarian neoplasm (D27.9)
•Solid ovarian neoplasm
•Adenocarcinoma withbladder
recti with solid part dd/ dermoid
metastasis cyst
(C21.8)
•Single life fetus cephalic presentation
Ovarian cancer
•Multiple uterineinadequate
myoma (D25.9) staging (C56.9)
•Primary infertility
Endometriosis ASRM14 years
grade(N97.9)
I (ASRM score 2 EFI score 7) (N80.1)
Non stage
CKD patentVbilateral
on HD tubes
Recent diagnosis:
Post Hysteroscopy
Endometriosis ASRM DnC o.i endometrial
grade polyp
IV post laparoscopy total hysterectomy left salphingo-oophorectomy
Post adhesiolysis
Postoperative on indication internal genitalia adhesion
diagnosis:
Post hysteroscopy D&C on indication endometrial hyperplasia
Post Minilaparatomy Interval Tubectomy Pomeroy
Cystic ovarian neoplasm mucinous type (C56.9)
Vesicovaginal
Uterine prolapse fistula
grade(N82.0)
III (N81.2 )
Hypertension stage II (I15.9
Endometrial
Multiple carcinoma
uterine myom (D26) stage IB was suspected
Hepatitisadenomyosis
Uterine B (18.1) (N80.0)
Ascites
Solid (R18)neoplasm malignancy was suspected (C56.9)
ovarian
Ascites (R18)
Solid ovarian
Uterine myoma neoplasm
(D25) malignancy was suspected (C56.9)
Endometrial Polyp (N84.0)
Ovarian cancer
Endometrial inadequate
Polyp (D27.9) therapy with metastase abdominal w
Benign neoplasm of ovary
Low grade squamous
Intramural uterine myoma intraepithelial
(D25.9) lesion (LGSIL) (R87.612)
Secondary
Internal infertile
genitalia 5 years (D25.9)
adhesion (N97.9)
Primary
Left infertile
ovarian PCO3 years (N97.9)
Right endometriosis
Preoperative diagnosis: cyst (N80.1)
Subserous uterine myoma
Uterine adenomyoma (N80.0) (D25.9)
Primary infertile 4 years
Right hydrosalpinx (N70.1) (N97.9)
Secondary Infertile 12
Right endometriosis years
cyst N97.9)
(N80.1)
Left cystic ovarian neoplasm (D27.9)
Cystic ovarian neoplasm with solid part, malignancy was suspe
•(N80.0)
•Endometriosis
ICD 10 of uterus
C56.9operative
Post Malignant neoplasm of right ovary
diagnosis
Post Fistuloraphy
Uterine prolapse gradeon indication
III Vesicovaginal fistula
+ Hipertensi stage II
Post left salphingo-oophorectomy o.i Left cystic ovarian neoplasm
Post adhesiolysis o.i internal genitalia adhesion
operative diagnosis
Post LEEP on indication LGSIL
Diagnosa
Recent Diagnosis
Post
Postdilatation andadhesiolysis
laparoscopy curettage onon indication death
indication conceptus
internal genitalia adhesion
Bilateral
Post patent tubes
laparoscopy rectovaginal nodule resection
Post laparoscopy
Rectocele grade IIadhesiolysis
Uterine
Post prolapse
operative grade II
diagnosis
•Cervical cancer
Recent diagnose: stage IIIC1
Post curratage on indication
COVID -19 was suspected ( U07.2) incomplete abortion
Single lifedd/
·Gastritis fetus intrauterine
HEGdd/ ( Z3A.37)
cholelithiasis (K25.9)
·Single life fetus intrauterine
•Post right salpingectomy on indication right tubo ovarian abscess
•Posttotal
Post stababdominal
wound drain hysterectomy – bilateral salpingoooforectomy on indication adenomyosis and bilateral endometriosis cyst
Endometriosis
Post Laparatomy grade IVsalpingoraphy
right ( ASRM scoreoi96) right tubal abortion
Moderate
•Post rightanemia
cystectomy on indication endometriosis cyst
•Endometriosis cyst grade I (ASRM scor3 4 EFI score
Post operative diagnosis
hysterectomy
Post left total – bilateral
salpingoooforectomy salpingoooforectomy
on indication on indication
left endometriosis cyst subserous uterine myom
Endometriosis
Post grade II (ASRM score
right salpingo-oophorectomy 11) endometriosis cyst + right hydrosalpinx
oi right
Postop
Post stab wound drain
diagnosis: Cervical cancer stage IIA (C53)
Rectocele grade II
Uterine prolapse grade II
Post menopause
Bilateral bleeding caused by malignancy was suspecte
patent tubes
Post laparoscopy adhesiolysis
Moderate anemia ( C64.9)
Uterine adenomyosis
Intramural uterine myoma( N80.0)
( D25.1)
Right endometriosis cyst ( N80.1)
Right endometriosis cyst (N80.1)
Left lateral vaginal wall laceration (O70.0)
Bilateral endometriosis
Right cystic cyst ( N80.1)
ovarian neoplasm (N83.02)
Secondary infertile 7 years ( N97.9)
Cervical Cancer Stage IIIB ( C53.9)
Mild anemia ( D64.9)
Ovarian Cancer Recurrent (C56.9)
Ovarian Cancer Recurrent ( C56.9)
Ovarian Cancer Inadequate staging ( C56.9)
GTNanemia
Mild Stage I FIGO Score 3 ( O01.9)
Recent diagnosis:
• Post curettage
Recent diagnosis:oi Incomplete abortion
• Postlaparotomy
post curettage oi Death conceptus
conservative surgical staging
Post right cystectomy on indication ovarian cyst
adhesiolisis
Post liver biopsy
Post adhesiolysis on indication internal genitalia adhesion
Bilateral patent tubes
Post laparascopy right salpingectomy on indication ectopic pregnancy on right tube
Vaginal Stumps prolapse grade IV (N81.2)
Rectocele grade IV (N. 81.6)
Post Fistuloraphy (57.84) on indication Vesicovaginal fistula (N
Abnormal uterine
Urinary tract bleeding
infection caused by O1 ( N93.0)
(N39.0)
Endocervical
Recent polyp + subserous penduculated myoma ( N84.)
Diagnosis
death conceptus
Post curettage on indication Incomplete Abortion
GTN Stage
Right I FIGO neoplasm
solid ovarian Score 3 ( O01.9)
( C56)
Left cystic ovarian neoplasm ( N83.02)
Cystic ovarian neoplasm with malignancy was suspected ( C56
Perineovaginal
Ovarian carcinomafistula (N82.3)stage IC
clinically
Ovarian cancer clinically stage IB
Bilateral patent tubes
Cysticadenomyosis
Post ovarian neoplasm malignancy
resection was suspected
on indication ( C56)
uterine adenomyosis
adhesiolysis
Post Operative on indication internal genitalia adhesion
Diagnosis:
Ovarian cancer
Diabetes clinically
Mellitus type II stage IIIC
Cervical cancer Stage IIIB ( C53.9)
Moderate anemia ( d64.9)
Cervical cancer Stage IIIB ( C53.9) was suspected
Thrombocytopenia ( D69.6)
Moderate anemia (D64.9)
Endometrial cancer Stage IIIA ( C54.1)
Thrombocytopenia ( D69.6)
Multiloculare cystic ovarian neoplasm with malignancy was suspected ( C56)
Identitas
IRT, 31 tahun, Banyuasin
DWI, 23 tahun
Identitas
Prosedur
Recurrent with rectal metastases Abdominal CT Scan
Digestive surgery assessment
Stage IIIB ( Complete therapy complete response) Pap’s smear 1 month later
Hospitalized
US Gynecology
Abdominal CT scan with contrast
PRC transfusion
Digestive surgery assessment
Cervical cancer stage IIB ( post NAC Chemotherapy) Laparotomy radical hysterectomy + lymphadenectomy + stab w
Cervical cancer stage IIB post radical hysterectomy + stab wound drain
Uterine adenomyosis Total hysterectomy with right salphingooforectomy
Bilateral endometriosis cyst Adhesiolysis
Internal genitalia adhesion Stab wound drain
Post laparotomy total hysterectomy with right salphingooforectomy _ stab wound drain
Plan for Laparoscopy diagnostic
Hysteroscopy
• diagnostic
Adhesiolysis
- Ascites fluid sampling
•procedure
Laparotomy surgical staging (54.1)
Cervical Biopsy (67.12)
· Laparotomy (54.1)
• Medicinalis
Plan for simulation radiotherapy ( April, 14th 2021)
BEP Chemotherapy 2nd course (. 99.25)
Plan for laparotomy surgical staging ( 99.25)
US evaluation ( 88.79)
Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)
ß-HCG evaluation ( April, 12th 2021) ( V72.4)
Chemotherapy
Vaginal biopsy (MR 7th course ( 99.25)
70.24)
Pap’s smear evaluation ( V72.4)
Plan for radiotherapy ( 92.29)
Radical hysterectomy( 68.4)
Pap’s smear evaluation ( V72.4)
Cervical biopsy ( 67.12)
TC transfusion ( 99.05)
BNO-IVP (87.79)
Laparotomy surgical staging ( 54.1)
Chemotherapy paclitaxel-carboplatin 4th course
Plan for laparotomy after 3rd course ( 54.1)
Abdominal CT Scan with contrast ( 88.01)
Pap’s smear ( V72.4)
Clinical staging
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Chemotherapy paclitaxel-carboplatin 4th course ( 99.25)
CaCO3 500 mg/8 hours ( 99.21)
Chemotherapy
PRC Transfusion paclitaxel-carboplatin
( 99.04) 1st course ( 99.25
Chemotherapy
Plan for Clinicalpaclitaxel-carboplatin
Staging 6th course ( 99.25)
MR chemotherapy 5th course ( 99.25)
MER chemotherapy 3rd course
Laparotomy VC ( 54.1)
Medicinalis ( 99.21)
Chemotherapy paclitaxel-carboplatin ( 99.25)
Plan for radiotherapy ( April, 12th 2021)
Chemotherapy paclitaxel-carboplatin 1st course _x000B_Plan for radiotherapy ( June, 21st 2021)
Chemotherapy paclitaxel-carboplatin 5th course
Chemohterapy CIM 4th course
Laparotomy VC ( 54.1)
Leuprolide acetate injection 1,88 mg 1 course ( 99.24)
Laparotomy
Control whenmyomectomy ( 68.29
patient had blood spotting
Infetile primer 8 years ( N97.9)
Anesthesia assessment
Anesthesia assessment
USG folicle at 2nd/ 3rd day of menstrual cycle
Plan for D
Vitamin sperm
PO analysis (V26.21
Leuprolide acetate 3.75 mg injection (IM) (99.2)
Plan for sperm analysis (V26.21)
Examine FSH, E2, prolactin (V72.62)
Evaluation ( 3 months)
HDLO ( 68.12)
Education
Analgetic
Medication (V0.79)
Topical estrogen cream (968.5)
Hospitalized
At this time there is no treatment from urogynecology division
(68.4- total abdominal hysterectomy)
Consult to urology departemtn
Continue euprolid acetate injection up to 6 courses
Plan for hysteroscopy D&C
Leuprolid acetate injection 3 courses
Plan for polypectomy and curettage (69.01- excusion or destruction of lesion or tissue of uterus and supporting structure; 69.09
Pathology anatomy examination
Fistuloraphy
Excision (K62.89
of lymph node (40.24)
TC transfusion ( 99.05
Stable in ward
Patient was discharged
Treated at non isolation ward and plan for Swab PCR
Plan for Clinical Staging
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Chemotherapy paclitaxel-carboplatin 4th course ( 99.25)
CaCO3 500 mg/8 hours ( 99.21)
PRC tranfussion
Incision and drainage
Marsupialisasi
US confirmation 88.78
General condition improvement
Patient was discharged at her own request
Discharge --> plan for control to urogynecology policlinic
65.4 Unilateral salpingo-oophorectomy
54.5 Lysis of peritoneal C53.61 Open incisional hernia repair with graft or prothesis.
54.5 Lysis of peritoneal C53.61 Open incisional hernia repair with graft or prothesis.
- Adhesiolysis (54.51- laparoscopic adhesiolysis of peritoneal adhesion)
Albumin flash ( 99.21)
Plan for radiotherapy ( 92.29)
Plan for radiotherapy ( 92.29)
Chemotherapy paclitaxel-carboplatin 6th course ( 99.25)
MER chemotherapy 3rd course
Urinary tract infection ( N39.0)
Mild anemia ( D64.9)
65.6 Bilateral salpingo-oophorectomy
Adhesiolysis (54.5)
Right Cystectomy
Left Salpingoooforectomy
Bilateral salpingo-oophorectomy
Passed away ( Tuesday, March 16th 2021; 05.30 PM)
Passed away march 17th 2021 at 09.30 AM
DNR
Bilateral salpingo-oophorectomy
- Adhesiolysis (54.51- laparoscopic adhesiolysis of peritoneal adhesion)
Excision of lymph node (40.24)
- Adhesiolysis (54.51- laparoscopic adhesiolysis of peritoneal adhesion)
65.6 Bilateral salpingo-oophorectomy
IUD extraction (99.71)
Chemotherapy paclitaxel-carboplatin 1st course ( 99.25)
FeSO4 1 tab/24 hours ( 99.21)
Chemotherapy pactliaxel-carboplatin1st course ( 99.25)
US gynecology ( March, 19th 2021)
Chemotherapy paclitaxel-carboplatin 3rd course ( 99.25)
BEP Chemotherapy 3rd course ( 99.25)
MR Chemotherapy 1st course ( 99.25)
MER chemotherapy 2nd course ( 99.25)
Rehecting
Mole Evacuation
Laparotomy
•Omentectomy Hysterectomy
•Stab wound
Laboratory drain
examination ( V72.62)
US confirmation ( 88.79)
US confirmation
Plan ( 88.79)
for radiotherapy ( 92.29)
Ranitidine 2x1 amp
Leucogen inj ( 99.21) ( 99.21)
Chemotherapy
Leucogen injectionpaclitaxel-carboplatin
( 99.21) 6th course ( 99.25)
Chemotherapy paclitaxel-carboplatin 4th course ( 99.25)
Hospitalized
MER chemotherapy
Leucogen injection ( 9th course ( 99.25)
99.21)
Digestive
PRC surgery( assessment
transfusion 99.04) ( 89.09)
CaCO3 3x1 tab ( 99.21)
Adhesiolysis
Laparotomy unilateral salpingo-oophorectomy (65.4)
Laparotomy unilateral salpingo-oophorectomy (65.4)
Consult to nutritionist
Laparotomy surgical staging (ascites fluid sampling, omentum mass biopsy, peritoneal mass biopsy, mesocolon mass biopsy) (
Laparotomy myomectomy (68.29)
Stable in ward
PRC Transfusion 600 cc ( 99.04)
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
Plan for
PRC radiotherapy
Transfusion (April, 28th 2021) ( 92.29)
( 99.04)
Leucogen
Passed awayinjection ( 99.21)
( March, 09th 2021 on 00.45 AM
Outcomes
Passedaway
Passed away((March,
March, 11th 2021;
2021 ;05.00
03.15PM)
AM)
Laparotomy Suboptimal Debulking : unilateral salphingo –oophorectomy, omentectomy ( C56.9)
Exploratory laparotomy (54.11)
Bilateral lymphadenectomy
Myomectomy
•Total abdominal hysterectomy
••Stab wound drain
••Stab wound drain
•
Post laparotomy right salpingo-oophorectomy on indication benign ovarian neoplasm
Laparotomy left salpingo-oophorectomy (65.4)
Transurethral resection of bladder tumor (57)
Laparotomy surgical staging (ascites fluid sampling, omentum mass biopsy, peritoneal mass biopsy, mesocolon mass biopsy)
Laparotomy myomectomy
Chromotubation (628.2) (68.29)
Procedure
Antibiotic
Adhesiolysis (54.51)
Chromotubation
Rectovaginal (66.0)
nodule resection
Adhesiolysis
Anterior (54.51) (70.8)
Colporrhaphy
PosteriorofColporrhaphy
-Biopsy bilateral pelvic(70.8)
lymph node (40.11)
-Omentectomy (54.4)
04.04.2021 (04.30 PM)
there were tissue and blood for 100 cc from curratage
Antimimetic
Discharged bypatient
·Laboratory examination request
( V72.62)
·If there is no contraindication à ondansentron 2x1 amp IV ( 99.21)
-Right salpingectomy (54.4)
-Stab wound(54.5)
Adhesiolisis drain (998.89)
•Anesthesia assessment
•Laparotomymyomectomy
·Laparotomy exploration (68.29)
-·Cystectomy
Hysterectomy (65.12)
(68.4)
- Bilateral salpingoooforectomy
Adhesiolisis(54.5) Hysterectomy(65.6)
(68.4)
Left salpingoooforectomy
stab wound drain (65.1)
(66.0)
Omentectomy (54.4)
Posterior Colporrhaphy (70.8)
Hysteroscopy
Chromotubation DnC ( 68.12)
(66.0)
Adhesiolysis (54.51)
Plan for radiotherapy ( 92.29)
Plan for radiotherapy ( 92.29)
Plan for radiotherapy ( 92.29)
Pap Smear Evaluation ( V72.3)
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Tumor marker evaluation ( V72.3)
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Digestive surgery consult ( 89.09)
Control 1 month later
Plan for radiotherapy ( 92.29)
Gynecology US Examination ( 88.79)
Plan for resection of vaginal mass after NAC
Sperm analysis (V26.21)
CaCO3 500 mg/ 8 hours PO
CaCO3 500 mg/ 8 hours PO
Control
Vitamin next month
E 1 tab/ 24 hours PO
Laboratory
Sperm examination
analysis (V26.21)(V72.62)
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
Chemotherapy paclitaxel-carboplatin 6th course ( 99.25)
Laparotomy
Internal radical
medicine hysterectomy
consult ( 89.09) ( 68.4)
Curettage
Plan
PRCfor Clinical staging
transfusion ( 99.04)
Radiotherapy
Chemotherapy( 92.29)
paclitaxel-carboplatin 1st course ( 99.25)
Plan for radiotherapy
Chemotherapy ( August, 19th 2021)
paclitaxel-carboplatin ( 92.29)
1st course ( 99.25)
Plan for radiotherapy ( June, 29th 2021) ( 92.29)
Tumor marker evaluation ( V72.4)
Laparoscopy conservative surgical staging ( 54.21)
Labia minora
laparotomy Excision (7109)
salpingo-oophorectomy
Resection of the left ovarian mass
Ascites cytology
Diagnosa Procedure
G4P2A1 12 weeks gestational age (Z3A.12) Control in 4 weeks
Single life fetus intrauterine (Z37.0) Medication
Folic acid 1x400mcg
CaCO3 tab 3x500mg
sulfas ferrous 1 x 1 tab
P3A1 post LSCS on indication Prior CS 2x Wound toilet
nephrotic syndrome (Z37.A) Antibiotic
Post tubectomy pomeroy (V26.51) Analgetic
Incomplete abortion (O03.4)
Recent diagnosis Curettage ( 69.02)
Post curettage oi incomplete abortion
Outcomes :
there were tissue and blood for 60 cc
G3P2A0 16 weeks gestational age not in labor (Z3A.16) Joint care with interna department
Recurrence case of pulmonary TB dd/ covid-19 was suspected (Conservative management
Single life fetus intrauterine ( Z37.0) GeneXpert
Medicinalis
Cervical cancer was suspected (C53.9) Cervical biopsy (67.12)
Moderate anemia (D64.9) Vaginal tamponade (75.8)
Chest-X-Ray ( 87.4)
US confirmation ( 88.79)
BNO-IVP ( 87.79)
PRC transfusion ( 99.04)
Clinical staging
Uterine adenomyosis ( N80.0) Analgetic ( 99.2)
Moderate anemia (D64.9) PRC Tranfusion (99.0)
P/ Adenomyosis resection (68.2)
AUB cause by M1 was suspected (N93.9) Observation of vital sign, bleeding
Left endometriosis cyst was suspected ( N80.1) General condition improvement
Moderate anemia (D64.9) US gynecology
Syphilis infection latent (A52.8) Re-check HIV in 2 weeks
HIV infection was suspected
Decreased of consciousness Observation of vital sign
Generalized onset motor tonic seizure c.b Non-hemorrhagic stroP1 care 🡪 after stabilization🡪 P2 OBGYN care
Joint care with Neurology, internal medicine
DD/ haemorrhagic stroke
SOL intracranial metastases
in 2nd course
in 2nd course
in 4th course
n 4th course
n 4th course
n 1st course
n 4th course
in 1st course
in 2nd course
in 2nd course
gooforectomy
y department
021)
ngooforectomy
supporting structure; 69.09- other dilatation and curettage)
, mesocolon mass biopsy) ( 54.1)
, mesocolon mass biopsy)
n and FHR , bleeding
n 2nd oucrse
n 6 course ( 99.25)
hyngooforectomy bilateral
condition improvement
n 3rd course ( 99.25)
17th 2021) ( 92.29)